<!DOCTYPE html><html lang="zh-CN"><head><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta charset="utf-8"><meta property="qc:admins" content="10210420621156375"><meta name="renderer" content="webkit"><title>zangyn - 雪球</title><script>var _write = document.write;
var write = function (str) {
  SNB = window.SNB || {};
  if (_write.apply) {
    SNB.docWrite = function (str) {
      _write.apply(document, arguments);
    }
  } else {
    SNB.docWrite = _write;
  }
};

document.write = write;
</script><meta name="keywords" content="zangyn - 雪球"><meta name="description" content="zangyn - 雪球"><!--<link rel="shortcut icon" href="http://xueqiu.com/favicon.ico">--><link rel="icon" type="image/png" href="http://assets.imedao.com/images/favicon.png"><style>html {display:none}</style><script>if (self == top) {
  document.documentElement.style.display = 'block';
} else if (top.location.host !== 'xueqiu.com') {
  top.location = self.location;
}
var WATCH = {};
WATCH.appStart = 1427781301644
WATCH.pageStart = (new Date()).getTime()</script><link rel="stylesheet" href="http://assets.imedao.com/style/bootstrap-84b5ee.css"><style>body{
  padding-top:40px;
}
/* TODO */
.search .dropdown-menu strong{
  height:12px;
  line-height:12px;
}</style><link rel="apple-touch-icon-precomposed" href="http://assets.imedao.com/images/icon-144.png"><script src="http://assets.imedao.com/js/xdomain-0.6.15.js"></script><script>xdomain.slaves({
  'https://xueqiu.com': '/proxy2.html',
  'https://im0.xueqiu.com': '/proxy2.html',
  'https://im1.xueqiu.com': '/proxy2.html',
  'https://im2.xueqiu.com': '/proxy2.html',
  'https://im3.xueqiu.com': '/proxy2.html',
  'https://im4.xueqiu.com': '/proxy2.html',
  'https://im5.xueqiu.com': '/proxy2.html',
  'https://im6.xueqiu.com': '/proxy2.html',
  'https://im7.xueqiu.com': '/proxy2.html',
  'https://im8.xueqiu.com': '/proxy2.html',
  'https://im9.xueqiu.com': '/proxy2.html'
});</script><script src="http://assets.imedao.com/js/SNB.lib.bundle-b11b47.js"></script></head><body id="his-profile" class=" isPC isNotMobile isNotPad"><script>SNB = window.SNB || {};
jQuery.extend(SNB, {
  data: {},
  env: "production",
  Views: {},
  Templates: {},
  Models: {},
  Collections: {},
  domain: {"host":"http://xueqiu.com","base":"http://api.xueqiu.com","photo":"http://photo.xueqiu.com","stock":"http://api.xueqiu.com","static":"http://assets.imedao.com","staticHttps":"https://js.xueqiu.com","upyun":"http://xqimg.b0.upaiyun.com","pdf":"http://doc.xueqiu.com","im":"http://api.xueqiu.com","shared":"/data/source/snowball-fe/shared/","file":"http://xqfile.imedao.com/"},
  currentUser: {"isGuest":true,"enableIM":true},
  jsVersion: {"05.jquery.cookie.js":"68e2a4","08.templates.js":"4aa7bf","SNB.TopicList.js":"870445","SNB.UsersList.js":"34f02b","SNB.atDialog.js":"b5dce3","SNB.base.js":"0e6b16","SNB.base_simple.js":"8d5f63","SNB.bind_verify.js":"118df1","SNB.calendar.js":"c65d9a","SNB.calendarDialog.js":"929cb0","SNB.calendarSubscribe.js":"e6012c","SNB.capitalReturnRateChart.js":"bd11c3","SNB.cardDialog.js":"ab3d1d","SNB.commentView.js":"bbb8d8","SNB.commonFriends.js":"230e08","SNB.companyInfo.js":"86e7f2","SNB.dialog.js":"1ba7c4","SNB.dm.js":"4c9d34","SNB.dmDialog.js":"c96117","SNB.downloadDialog.js":"68595d","SNB.editor.emotion.js":"ccd772","SNB.editor.js":"adb8a9","SNB.eventShare.js":"7b230c","SNB.financeTableDataInfo.js":"63138a","SNB.follower.js":"83577e","SNB.friends.js":"d90729","SNB.g.bar.js":"8d17c0","SNB.guest.js":"a94f90","SNB.guide.js":"28902b","SNB.helpers.js":"d5327e","SNB.his_home.js":"468d25","SNB.holdStockChart.js":"7fb688","SNB.home.js":"da999e","SNB.hotStock.js":"320cd1","SNB.im.contacts.js":"3d5779","SNB.im.dialog.js":"ee29f9","SNB.im.emotions.js":"158b2d","SNB.im.group_applys.js":"5c11f0","SNB.im.group_joined.js":"3f1895","SNB.im.js":"43351a","SNB.im.message.js":"1c9f8a","SNB.im.model.js":"a8324f","SNB.im.net.js":"ec4486","SNB.im.peer_chat.js":"cb13f1","SNB.im.session_item.js":"bbffaa","SNB.im.sessions_list.js":"eb2ad1","SNB.im.setting.js":"ac0ed0","SNB.im.stranger.js":"8ea9a5","SNB.im.utils.js":"6a455e","SNB.imeigu_fund_topic.js":"712871","SNB.imeigu_index.js":"d4f2e9","SNB.index.login.js":"bba5e1","SNB.inner_trade.js":"7d8321","SNB.interest.js":"eeb1f8","SNB.interview.js":"fa9ef6","SNB.kline.js":"b097fb","SNB.lib.bundle.js":"b11b47","SNB.lib.mobile.js":"8eda9f","SNB.modify_email.js":"0cb2c6","SNB.newChart.js":"453bf1","SNB.newChart.mobile.js":"089c9a","SNB.newProfile.js":"50704d","SNB.password.js":"8bf5ac","SNB.pdfDialog.js":"edc173","SNB.performance-year.js":"55e5b8","SNB.performance.js":"b83bda","SNB.performanceChart.js":"0cc6bc","SNB.performanceView.js":"fde3d9","SNB.performance_mobile.js":"2890ea","SNB.personality.js":"3a3a3d","SNB.portfolio.js":"b332e5","SNB.portfolioNew.js":"291c15","SNB.portfolioShareDialog.js":"b581bf","SNB.profile_info.js":"621d95","SNB.recommend.js":"0444f1","SNB.renderTableTrHtml.js":"d9ecf0","SNB.renderUserView.js":"0ea1a6","SNB.reportSpam.js":"418c1f","SNB.repostDialog.js":"7df4cb","SNB.sameFriend.js":"b18a13","SNB.search.js":"11b42e","SNB.search_ipad.js":"62a216","SNB.search_stock_ipad.js":"6910d7","SNB.setting_user.js":"5d7e30","SNB.shareDialog.js":"1dee89","SNB.similarUsers.js":"72068a","SNB.singleStock.js":"2f733b","SNB.status-edit.js":"a9ae8a","SNB.status.js":"1172f0","SNB.status_mobile.js":"7e19fa","SNB.stockActiveUser.js":"396eeb","SNB.stockFollowers.js":"e124c9","SNB.stockList.js":"941ade","SNB.stockList_new.js":"e5b606","SNB.stockNews.js":"311d94","SNB.stockRecommend.js":"352bad","SNB.stockScreener.js":"352de4","SNB.stockStatus.js":"7af8bd","SNB.talks.js":"e19cae","SNB.third_oauth.js":"1b9e2a","SNB.tipsTalk.js":"83e04f","SNB.tipsTopic.js":"624f0b","SNB.today.js":"ff42db","SNB.today.lib.js":"19681e","SNB.today_topic.js":"9f7844","SNB.tooltip.js":"b57764","SNB.topInfluence.js":"89f31e","SNB.trans.js":"ae4d82","SNB.tweetDialog.js":"9eb539","SNB.typeahead.js":"6c0b76","SNB.userRecommend.js":"5dcade","SNB.userRemark.js":"001ff1","SNB.validator.js":"32794c","SNB.weiboUser.js":"81e080","TGJSBridge.js":"4aaeff","WdatePicker.js":"eb9586","ajaxfileupload.js":"59627b","backbone.0.9.10.js":"5d519b","backbone.js":"d013f1","bootstrap.js":"6bd6fa","calendar.js":"9795e3","checkLogin.js":"38a9a1","config.js":"799ccf","d3.v2.min.js":"1ef3b6","fittext.js":"45db6e","flexpaper.js":"56a735","flexpaper_handlers.js":"623c12","fullcalendar.js":"26781c","g.bar.js":"32785d","g.line-min.js":"2db247","g.pie.js":"46e2f1","g.raphael.js":"630b74","hammer.js":"ec2456","hc_exporting.js":"bb5d9e","hc_grid.js":"3b9851","highcharts.js":"122285","highlight.js":"21d2c6","iScroll.js":"834870","im2014.js":"0216be","im_group_apply.js":"930e3b","imeigu_portfolioIframe.js":"8e3134","imgPlugin.js":"1cb5de","imgUpload.js":"0986a1","infinity.min.js":"0c5941","jquery.color.js":"875798","jquery.galleriffic.js":"e6186f","jquery.hammer.js":"e02a44","jquery.history.js":"6f8651","jquery.imgareaselect.js":"a9d059","jquery.js":"d80a03","jquery.lazyload.min.js":"fb3951","jquery.mousewheel.js":"41ebd2","jquery.pjax.js":"7ccac8","jquery.plugin.pullToRefresh.js":"35465b","jquery.rotate.1-1.js":"60d180","jquery.simplePagination.js":"420bda","jquery.tagsinput.js":"0dce2d","jquery.ui.js":"9ee05e","jquery.uploadify.js":"aac61a","jquery.validate.js":"555531","jquery.vticker.js":"5104ed","jquery.watermark.js":"0cc691","login.js":"094d42","moment.js":"b01d4e","morris.min.js":"92098e","mustache.js":"fbf1b1","perfect-scrollbar-0.4.8.with-mousewheel.min.js":"1bd536","raphael.js":"ea1c64","responsive_slides.min.js":"ea733a","sea.js":"1264a2","share-to-xueqiu.js":"ae4237","single.js":"36ac66","slides.jquery.js":"cd66ff","step01.js":"ceaeeb","subscribe.js":"7d760a","underscore.js":"51b489","userSearch.js":"54d13d","xdomain-0.6.15.js":"575cd5","xdomain.js":"c4e376","zepto.js":"6cdcc6","My97DatePicker/WdatePicker.js":"eb9586","My97DatePicker/calendar.js":"9795e3","SNB.lib.bundle/00.sea.js":"24e81c","SNB.lib.bundle/01.JSON.js":"b459a8","SNB.lib.bundle/02.modernizr.js":"f634b5","SNB.lib.bundle/03.jquery.js":"53538f","SNB.lib.bundle/04.jquery.ui.js":"96c17c","SNB.lib.bundle/05.jquery.cookie.js":"68e2a4","SNB.lib.bundle/06.underscore.js":"d97ed3","SNB.lib.bundle/07.backbone.js":"8a9a44","SNB.lib.bundle/08.templates.js":"4aa7bf","SNB.lib.bundle/10.jade.runtime.js":"1fc7ae","SNB.lib.mobile/1.zepto.min.js":"acaeac","SNB.lib.mobile/2.underscore.js":"c2da07","SNB.lib.mobile/iscroll.js":"4a55be","bootstrap/bootstrap-alert.js":"a9f081","bootstrap/bootstrap-button.js":"ce03ae","bootstrap/bootstrap-carousel.js":"62b76a","bootstrap/bootstrap-collapse.js":"9be616","bootstrap/bootstrap-dropdown.js":"af96b6","bootstrap/bootstrap-modal.js":"cf302e","bootstrap/bootstrap-popover.js":"a4e6a7","bootstrap/bootstrap-scrollspy.js":"a88d39","bootstrap/bootstrap-tab.js":"8f2b45","bootstrap/bootstrap-tooltip.js":"682437","bootstrap/bootstrap-transition.js":"17fa23","bootstrap/bootstrap-typeahead.js":"97f107","common/SNB.helpers.js":"2bdc5e","common/backbone_1.1.2.js":"8531c9","common/css3-mediaqueries.js":"f83d37","common/fastclick.js":"753522","common/jquery-1.9.1.js":"b8b878","common/json.js":"b459a8","common/lib.js":"de2f7c","common/sea-2.3.0.js":"c823d9","common/sea.js":"24e81c","common/underscore_1.6.0.js":"3ffba8","common/util.js":"183faf","common/zepto-core-fx.1.1.3.js":"27e274","common/zepto-deferred.js":"977158","cube/cube_detail.js":"b26446","cube/cube_detail_m.js":"1ea5eb","cube/cube_discover.js":"b16cdd","cube/cube_discover_m.js":"b9ea8b","cube/cube_edit.js":"d058ee","cube/cube_guide.js":"88a7d5","cube/cube_recommend.js":"eb4aa8","cube/post_grid.js":"730811","cube/profile_cubes.js":"593e28","cube/range_slider.js":"358302","cube/stock_edit_modal.js":"9ad913","highcharts/jquery-1.6.4.min.js":"526f75","im2014/base.adapter.deliver.js":"17ba5b","im2014/base.adapter.js":"e895d8","im2014/base.config.js":"710ff1","im2014/base.js":"58869d","im2014/base.localstorage.js":"57720d","im2014/base.net.js":"540257","im2014/base.utils.js":"8cb3f7","im2014/db.contacts.js":"536985","im2014/db.groups.js":"aebe8f","im2014/db.js":"b1164d","im2014/db.message.helper.js":"0fa7e8","im2014/db.messages.js":"cd2db6","im2014/db.sessions.js":"b428e2","im2014/im.js":"3675e3","im2014/session.dialog.js":"34f336","im2014/session.editor.js":"fc99c9","im2014/session.gmm.js":"44c0a0","im2014/session.item.js":"2f722e","im2014/session.joingroup.js":"34f898","im2014/session.list.js":"35a7ff","im2014/session.message.js":"30b56c","im2014/session.setting.js":"a5fdcb","im2014/widget.emotion.js":"e07cbb","im2014/widget.joingroup.js":"b2ee4c","im2014/widget.requestjoingroup.js":"319aaa","im2014/widget.search.js":"2d2eda","im2014/widget.uploader.js":"e1abec","im2014/widget.viewer.js":"93c152","imeigu/xueqiu_popup.js":"61979d","lang/en.js":"c6550c","lang/zh-cn.js":"a606a6","lang/zh-tw.js":"4e0fdb","lib/autoresize.js":"f853a5","lib/chai.js":"a0130d","lib/jquery.easing.1.3.js":"008f85","lib/jquery.fullPage.js":"f69025","lib/mocha.js":"8799cd","lib/store.js":"9c7667","lib/ueditor.js":"2e0f51","lib/upload.js":"8837c4","pages/home.js":"1112bf","pages/single.js":"0a3e7d","widget/TSNB.addfriend.js":"f04fd7","widget/TSNB.addpdf.js":"d185b8","widget/TSNB.addstock.js":"0c459a","widget/TSNB.at.js":"a5ebeb","widget/TSNB.bindverify.js":"f3ea69","widget/TSNB.home-editor.js":"123ca2","widget/TSNB.newuser-guide.js":"3bc710","widget/TSNB.people-autocomplete.js":"92ed61","widget/TSNB.performance.js":"27b5e6","widget/TSNB.sharestatus.js":"16e249","widget/TSNB.stockalert.js":"1cb0fd","widget/TSNB.stockgroup.js":"7baec6","widget/TSNB.typeahead.js":"6e6634","widget/aside.js":"46008f","widget/backbone1.1.2.js":"181b4a","widget/bootstrap.js":"abac2a","widget/donate.js":"312591","widget/donate_tooltip.js":"435b5f","widget/editor.js":"25fcd3","widget/emotions.js":"623bc3","widget/favorite.js":"e356ee","widget/forward.js":"fb609b","widget/global_pin.js":"4c1878","widget/lodash.underscore.js":"1854ff","widget/profile_pin.js":"fb4311","widget/report_spam.js":"2e5e63","widget/repost_comment.js":"4bb3ae","widget/share.js":"6e71c0","widget/status.js":"d06d1e","widget/underscore1.6.0.js":"4d7fd6","widget/util.js":"c0629c","My97DatePicker/lang/en.js":"c6550c","My97DatePicker/lang/zh-cn.js":"a606a6","My97DatePicker/lang/zh-tw.js":"4e0fdb","bootstrap/tests/phantom.js":"e38dfa","bootstrap/tests/server.js":"21e92a","common/lib/jquery-1.9.1.js":"3dd6ee","common/lib/sea-2.3.0.js":"c823d9","common/lib/underscore_1.6.0.js":"834fa8","common/util/image.js":"73664d","common/util/jade.runtime.js":"aed6b5","common/util/jquery.extend.js":"cb4243","common/util/observer.js":"648151","common/util/password.js":"ef4528","common/util/upload.js":"8f1294","pages/about/app.js":"eecbff","pages/about/app_mobile.js":"7db607","pages/broker/TSNB.bind.js":"e8ed5d","pages/consultant/consultant-market.js":"2bc801","pages/event/TSNB.year-summary-mobile.js":"73f230","pages/event/TSNB.year-summary.js":"daff60","pages/event/cmc.js":"a7c273","pages/home/timeline.js":"1112bf","pages/invest/SNB.chart_base.js":"285f6f","pages/invest/SNB.fund_chart.js":"4a2cb1","pages/invest/SNB.mobile_chart.js":"bc032b","pages/invest/SNB.mobile_stock.js":"d942d7","pages/invest/SNB.profile_broker_rank.js":"85311d","pages/invest/SNB.rank.js":"677dd5","pages/invest/chart.js":"02e6ce","pages/pay/deposit-mobile.js":"799d95","pages/pay/deposit.js":"e37ac4","pages/pay/donate-mobile.js":"153feb","pages/pay/pin.js":"1804ea","pages/pay/subscribe-mobile.js":"c6187b","pages/pay/withdraw.js":"952521","pages/sns/index.js":"a6c885","pages/sns/single.js":"120bdc","pages/today/mobile.index.js":"f72378","pages/user/login.js":"ff5499","widget/aside/TSNB.ad.js":"55466e","widget/aside/TSNB.hot-stocks.js":"44327c","widget/aside/TSNB.interesting-people.js":"b01b82","widget/aside/TSNB.other-services.js":"70e391","widget/aside/TSNB.recommend-people.js":"7ddb30","widget/aside/TSNB.sysnotify.js":"e50d01","widget/aside/TSNB.today-talk.js":"8fa37c","widget/bootstrap/affix.js":"f014e8","widget/bootstrap/alert.js":"915f20","widget/bootstrap/bootstrap-datepicker.js":"daa8d6","widget/bootstrap/button.js":"3a8a2e","widget/bootstrap/carousel.js":"f763e0","widget/bootstrap/collapse.js":"c9ceab","widget/bootstrap/dropdown.js":"164604","widget/bootstrap/modal.js":"d390dd","widget/bootstrap/popover.js":"8c9993","widget/bootstrap/scrollspy.js":"37bd38","widget/bootstrap/tab.js":"5df6c4","widget/bootstrap/tooltip.js":"b973d7","widget/bootstrap/transition.js":"7af948","widget/bootstrap/typeahead.js":"1e1e67","widget/editor/at.js":"41b184","widget/editor/emotion.js":"bd52eb","widget/editor/umeditor.config.js":"ed3336","widget/editor/umeditor.js":"6b7121","widget/editor/zh-cn.js":"16b3e4","widget/flexpaper/flexpaper.js":"56a735","widget/flexpaper/flexpaper_handlers.js":"39b20d","widget/mobile/action.js":"43495d","widget/mobile/form.js":"03c77e","widget/mobile/modal.js":"309f6a","widget/mobile/overlay.js":"44e1eb","widget/status/comment.js":"239e91","widget/status/data.js":"d2678b","widget/status/pdf.js":"0af8cc","widget/status/pin.js":"4dce9c","widget/tmp/SNB.base.js":"73a62a","widget/tmp/json.js":"b459a8","widget/util/TSNB.donate.js":"dabf92","widget/util/areas.js":"4f6252","widget/util/modal.js":"0a947f","widget/util/notice.js":"c2c3a1","widget/util/share.js":"8c017a","widget/util/tooltip.js":"30a8e8","widget/util/typeahead.js":"f70471","widget/util/user.js":"9b9c3a","bootstrap/tests/unit/bootstrap-alert.js":"93d6ac","bootstrap/tests/unit/bootstrap-button.js":"996b53","bootstrap/tests/unit/bootstrap-carousel.js":"54a2cf","bootstrap/tests/unit/bootstrap-collapse.js":"1b1262","bootstrap/tests/unit/bootstrap-dropdown.js":"6a491c","bootstrap/tests/unit/bootstrap-modal.js":"6dd5a0","bootstrap/tests/unit/bootstrap-phantom.js":"940ffb","bootstrap/tests/unit/bootstrap-popover.js":"4f65eb","bootstrap/tests/unit/bootstrap-scrollspy.js":"bd7b2c","bootstrap/tests/unit/bootstrap-tab.js":"63f9fc","bootstrap/tests/unit/bootstrap-tooltip.js":"fc2c1c","bootstrap/tests/unit/bootstrap-transition.js":"a1b2cc","bootstrap/tests/unit/bootstrap-typeahead.js":"2f86e0","bootstrap/tests/vendor/jquery.js":"fcf997","bootstrap/tests/vendor/qunit.js":"a8c0db","pages/invest/chart/TSNB.chart.base.js":"33cd3a","pages/invest/chart/TSNB.chart.compare.js":"6b4c52","pages/invest/chart/TSNB.chart.event.js":"23af89","pages/invest/chart/TSNB.chart.kline.js":"3a1e79","pages/invest/chart/TSNB.chart.status.js":"62d5f1","pages/invest/chart/TSNB.chart.stock.js":"770897","pages/invest/chart/TSNB.chart.thumbnail.js":"52101d","pages/invest/hq/TSNB.compare_ah.js":"8dcaea","pages/invest/portfolio/TSNB.create-portfolio-group.js":"d9e67b","pages/invest/portfolio/TSNB.delete-portfolio-group.js":"af94fb","pages/invest/portfolio/TSNB.delete-portfolio.js":"1a6838","pages/invest/portfolio/TSNB.manage-portfolio-group.js":"1b0504","pages/invest/portfolio/TSNB.portfolio-util.js":"d78b8f","pages/invest/portfolio/TSNB.portfolio.js":"6580b6","pages/invest/portfolio/TSNB.stock-autocomplete.js":"cc5d2e","pages/sns/index/cube.js":"1f5d94","pages/sns/index/login.js":"665dd7","pages/sns/index/markets.js":"b51353","pages/sns/index/promotion.js":"aa01d3","pages/sns/index/stocks.js":"47fe9b"},
  cssVersion: {"about.css":"8a68c7","activate_bar.css":"90db89","bootstrap-lite.css":"09c973","bootstrap.css":"84b5ee","bootstrap_full.css":"66069a","bootstrap_tab_xueqiu.css":"69dee9","bootstrap_tab_xueqiu_white.css":"5492e5","button.css":"23513c","chart.css":"d41d8c","comment.css":"dbfbd5","connect_link.css":"0edf0b","default.css":"165b51","default_mobile.css":"264592","dh.css":"a34780","dialog.css":"828547","editor.css":"57d8ef","editor_inline.css":"7d7563","flexpaper.css":"ecc108","form.css":"c845bd","fullcalendar.css":"b1f726","guide_overlay.css":"9dd1cf","hots-statuses.css":"181d4e","icon.css":"680a07","im.css":"aa2f71","im2014.css":"dbd489","imgroup.css":"5445f8","jinNang.css":"4bd30a","jinnang_1394597838763.css":"4bd30a","jquery.tagsinput.css":"3f47e0","jquery.ui.css":"279647","mentions_block.css":"4b58aa","mocha.css":"a5dea9","mystatus.css":"272433","newChart.css":"5d9be9","pdfviewer.css":"720dd9","performance-year-mobile.css":"a17f1a","performance-year.css":"317994","performanceChart.css":"2589d4","personality-ie8.css":"6a37b0","personality.css":"c723c4","pop_login.css":"8f20df","portfolioIframe.css":"c85adf","portfolioNew.css":"4f2887","profile.css":"0737fc","profile_info.css":"4b5978","profile_operations.css":"a0abbd","profile_status.css":"01d683","pull-to-refresh.css":"3e5b69","searchBar.css":"aeef28","simplePagination.css":"b23401","snowbrick.css":"ccc31a","status_mobile.css":"4c93b3","status_operate_btn.css":"0872af","tab-setting.css":"506d45","today_topic.css":"a8f864","tooltip.css":"820355","uploadify.css":"d5b49f","userRecommend.css":"beabbe","user_list.css":"bb06fd","widget.css":"88e99b","widget_user.css":"d1e0c0","common/base.css":"2262f2","common/grid.css":"ad0354","common/iconfont.css":"5cf08f","common/layout.css":"746a95","common/menu.css":"985468","common/mobile.css":"3362b1","common/mod.css":"e27423","common/modal.css":"f9111d","common/nav-bar.css":"c37184","common/pager.css":"0d5b09","common/reset.css":"e2dffc","common/var.css":"d41d8c","cube/cube_card.css":"ae3e1a","cube/cube_detail.css":"d97083","cube/cube_detail_m.css":"9ac92d","cube/cube_discover.css":"30d439","cube/cube_discover_m.css":"d02a1d","cube/cube_edit.css":"f5208f","lib/jquery.fullPage.css":"3dfa38","pages/TSNB.about.css":"28449a","pages/home.css":"3ef6f1","pages/imeigu.css":"d51b5b","pages/post.css":"16fd7a","pages/profile.css":"093e27","pages/status.css":"cc43c8","pages/tip.css":"9bc5a0","touch/common.css":"1c57df","touch/normal.css":"d536b7","widget/TSNB.comment.css":"705fe6","widget/TSNB.donate.css":"708f8a","widget/TSNB.donate_tooltip.css":"672acf","widget/TSNB.performance.css":"588cce","widget/TSNB.portfolio_dialog.css":"68b2cb","widget/TSNB.portfolio_user_dialog.css":"9ad4f2","widget/TSNB.report_spam.css":"3e795c","widget/TSNB.share.css":"f36d77","widget/TSNB.status.css":"024cfd","widget/TSNB.user_dialog.css":"81075a","widget/btn.css":"9fdda0","widget/datepicker.css":"d683e7","widget/donate.css":"ab255d","widget/donate_tooltip.css":"9e0336","widget/global_pin.css":"92b1cf","widget/modal.css":"5fc4e9","widget/profile_pin.css":"60296d","common/css3/inline-block.css":"bb8c38","pages/about/animation.css":"1e4355","pages/about/app.css":"d919d8","pages/about/app_mobile.css":"5b4c12","pages/about/share.css":"6712c8","pages/consultant/consultant.css":"138686","pages/event/TSNB.year-summary-mobile.css":"864fa2","pages/event/TSNB.year-summary.css":"a868f5","pages/event/cmc-mobile.css":"7fe9f7","pages/event/cmc.css":"8d1acc","pages/home/home-editor.css":"a4a479","pages/home/newuser-guide.css":"23dd61","pages/home/widgets.css":"cfae61","pages/index/cube.css":"cc49b2","pages/index/default.css":"417e7b","pages/invest/dealList.css":"79d551","pages/invest/mobile_chart.css":"31d833","pages/invest/mobile_performance.css":"16e7bb","pages/invest/mobile_stock.css":"4a4c6d","pages/invest/profile_broker_rank.css":"55a18e","pages/invest/rank.css":"4d6196","pages/invest/stock_chart.css":"0eeda7","pages/mobile/common.css":"004801","pages/mobile/vars.css":"d41d8c","pages/pay/subscribe-mobile.css":"128827","pages/pay/wallet-mobile.css":"583bc0","pages/pay/wallet.css":"f7af19","pages/pin/pin-mobile.css":"bf2ba8","pages/sns/TSNB.single.css":"775597","pages/sns/home.css":"8f62db","pages/today/index-mobile.css":"a95cc9","pages/user/login.css":"ba73c8","widget/bootstrap/alerts.css":"2c520b","widget/bootstrap/badges.css":"da050d","widget/bootstrap/bootstrap.css":"971848","widget/bootstrap/breadcrumbs.css":"b9ab35","widget/bootstrap/button-groups.css":"a7c65b","widget/bootstrap/buttons.css":"a73cc0","widget/bootstrap/carousel.css":"93e128","widget/bootstrap/close.css":"30812b","widget/bootstrap/code.css":"fab06a","widget/bootstrap/component-animations.css":"63295e","widget/bootstrap/dropdowns.css":"d91661","widget/bootstrap/forms.css":"1dac09","widget/bootstrap/glyphicons.css":"024db0","widget/bootstrap/grid.css":"7f9bd0","widget/bootstrap/input-groups.css":"fc56c7","widget/bootstrap/jumbotron.css":"cf17ad","widget/bootstrap/labels.css":"3e0971","widget/bootstrap/list-group.css":"ec9751","widget/bootstrap/media.css":"ecbd91","widget/bootstrap/mixins.css":"a0cb66","widget/bootstrap/modals.css":"5b2682","widget/bootstrap/navbar.css":"abacbf","widget/bootstrap/navs.css":"9fbe5c","widget/bootstrap/normalize.css":"ddcb0b","widget/bootstrap/pager.css":"7be0a4","widget/bootstrap/pagination.css":"eaa566","widget/bootstrap/panels.css":"d53a2d","widget/bootstrap/popovers.css":"93bafa","widget/bootstrap/print.css":"b11602","widget/bootstrap/progress-bars.css":"580cf9","widget/bootstrap/responsive-embed.css":"1c5626","widget/bootstrap/responsive-utilities.css":"2db01f","widget/bootstrap/scaffolding.css":"0fc3a2","widget/bootstrap/tables.css":"462165","widget/bootstrap/theme.css":"52929d","widget/bootstrap/thumbnails.css":"b96eb4","widget/bootstrap/tooltip.css":"c060af","widget/bootstrap/type.css":"c8dff8","widget/bootstrap/utilities.css":"d3b1aa","widget/bootstrap/variables.css":"d41d8c","widget/bootstrap/wells.css":"578e1c","widget/mobile/modal.css":"f2f776","widget/mobile/normal.css":"d536b7","widget/mobile/top-bar.css":"f4eb52","widget/umeditor/editor.css":"5f1892","widget/umeditor/umeditor.css":"7eb569","widget/util/page.css":"3ea87c","pages/home/widgets/ad.css":"4f1e5e","pages/home/widgets/hot-stocks.css":"9c722b","pages/home/widgets/interesting-recommend.css":"25f080","pages/home/widgets/my-nav.css":"c4c64e","pages/home/widgets/other-services.css":"d76f0d","pages/home/widgets/sysnotify.css":"116c48","pages/invest/portfolio/group.css":"3e96d2","pages/invest/portfolio/portfolio.css":"f2f39b","widget/bootstrap/mixins/alerts.css":"d41d8c","widget/bootstrap/mixins/background-variant.css":"d41d8c","widget/bootstrap/mixins/border-radius.css":"d41d8c","widget/bootstrap/mixins/buttons.css":"d41d8c","widget/bootstrap/mixins/center-block.css":"d41d8c","widget/bootstrap/mixins/clearfix.css":"d41d8c","widget/bootstrap/mixins/forms.css":"d41d8c","widget/bootstrap/mixins/gradients.css":"d41d8c","widget/bootstrap/mixins/grid-framework.css":"d41d8c","widget/bootstrap/mixins/grid.css":"2f25b9","widget/bootstrap/mixins/hide-text.css":"d41d8c","widget/bootstrap/mixins/image.css":"d41d8c","widget/bootstrap/mixins/labels.css":"d41d8c","widget/bootstrap/mixins/list-group.css":"d41d8c","widget/bootstrap/mixins/nav-divider.css":"d41d8c","widget/bootstrap/mixins/nav-vertical-align.css":"d41d8c","widget/bootstrap/mixins/opacity.css":"d41d8c","widget/bootstrap/mixins/pagination.css":"d41d8c","widget/bootstrap/mixins/panels.css":"d41d8c","widget/bootstrap/mixins/progress-bar.css":"d41d8c","widget/bootstrap/mixins/reset-filter.css":"d41d8c","widget/bootstrap/mixins/resize.css":"d41d8c","widget/bootstrap/mixins/responsive-visibility.css":"d41d8c","widget/bootstrap/mixins/size.css":"d41d8c","widget/bootstrap/mixins/tab-focus.css":"d41d8c","widget/bootstrap/mixins/table-row.css":"d41d8c","widget/bootstrap/mixins/text-emphasis.css":"d41d8c","widget/bootstrap/mixins/text-overflow.css":"d41d8c","widget/bootstrap/mixins/vendor-prefixes.css":"d41d8c"},
  staticDomain: 'http://assets.imedao.com',
  bid : ''
});

SNB.data.access_token =  $.cookie("xq_a_token") || "7fd433866f17942022661a942c06f2b5fe387c88";
</script><!-- 防止局域网缓存用户信息--><script>(function(){
  var search = window.location.search || '';
  if (search.indexOf('_=') === -1 && SNB.bid !== '' && document.cookie && document.cookie.indexOf('bid=' + SNB.bid) === -1) {
    var searchArr = search.split('&');
    searchArr.push('_=' + (+new Date).toString(36));
    window.location.search = search.join('&');
  }
})();
</script><script src="http://assets.imedao.com/js/05.jquery.cookie.js"></script><script>function delCookie(name){//为了删除指定名称的cookie，可以将其过期时间设定为一个过去的时间
  var date = new Date();
  date.setTime(date.getTime() - 10000);
  document.cookie = name + '=a; expires=' + date.toGMTString();
}
/*
if(!$.cookie('xq_refresh') && $.cookie('xq_a_token')){
  $.ajax({
    url: '/user/refreshCookie',
    async: false
  }).done(function(){
    delCookie('xq_a_token');
    delCookie('xq_r_token');
    delCookie('xq_token_expire');
  });
}
*/
jQuery(function($){
  $('.navbar a.exit').on('click', function(){
    try{
      delCookie('xq_a_token');
      delCookie('xq_r_token');
      delCookie('xq_token_expire');
    } catch(e){
      console.log(e);
    }
  });
});</script><script src="http://assets.imedao.com/js/SNB.helpers-d5327e.js"></script><script>SNB.profileUser = {"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":130,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png!50x50.png","profile_image_url_small":"community/default/avatar.png!30x30.png"}</script><noscript><style>html {
  display: block
}</style><p class="ie6">当前浏览器禁用了JavaScript，导致不能正常使用雪球的功能，请打开JavaScript后再访问本站。</p></noscript><!--[if lt IE 8]><div class="ie6">你正在使用的浏览器版本过低（IE7或IE7以下，包括套用了IE内核的360浏览器、搜狗浏览器等）。<br />如果不能正常浏览本站或某些功能无法使用，请到微软官网下载升级 <a href="http://windows.microsoft.com/zh-CN/internet-explorer/downloads/ie">Internet Explorer</a> 或使用 <a href="http://www.google.com/chrome/">谷歌 Google Chrome</a> 浏览器。</div><![endif]--><div class="temp"></div><div class="navbar navbar-fixed-top"><div class="navbar-inner"><div class="container"><h1 id="logo"><a href="/"><img title="返回我的首页" src="http://assets.imedao.com/images/logo@2x.png" width="54px" height="30px" alt="雪球"></a></h1><div class="search"><form method="get" action="/k"><input id="quick-search" name="q" type="text" autocomplete="off" placeholder="搜索 股票/讨论/用户/群组" class="typeahead"></form><span class="icon"><i></i></span></div><ul class="nav pull-right account notlogined"><li><a href="/account/reg" class="reg">注册</a></li><li><a href="/" class="login">登录</a></li></ul></div></div></div><!--!=css('im.css')--><script>seajs.config({
  timeout: 60000,
  preload: [SNB.jsVersion && _.keys(SNB.jsVersion).length ? 'SNB.base-' + SNB.jsVersion['SNB.base.js'] + '.js' : 'SNB.base.js']
})
</script><script>seajs.use("SNB.guest.js")
</script><script>;(function () {
  var keys = _.keys(SNB.jsVersion)
    , map = [];
    
  if (keys.length) {
    _.each(keys, function(k) {
      var reg = new RegExp('\\/(' + k.replace(/\./g, '\\.') + ')(\\?.*|$)');
      
      map.push([reg, function (all, fileName, param) {
        var result = '/' + fileName.replace(/\.js$/i, '') + '-' + SNB.jsVersion[k] + '.js';
        
        if (param) {
          result += param;
        }
        
        return result;
      }]);
    });
    
    seajs.config({
      map: map
    });
  }
}())
</script><!-- test config--><script src="http://assets.imedao.com/js/bootstrap-6bd6fa.js"></script><div id="center" class="container"><div class="main"><div style="display:none" class="loading"></div><div class="wrapper"><link rel="stylesheet" href="http://assets.imedao.com/style/pages/profile-093e27.css"><div class="profile_box container "><div class="profile_box_behaviour"><div class="profile_box_operations"><div class="profile_operations"><ul class="operations relation"><li class="relationship"><span class="op addFriendBtn"><b>＋</b>加关注</span></li><li><a href="javascript:;" data-toggle="at" data-target="zangyn" class="at">@他</a></li><li><a href="javascript:;" class="block">拉黑</a></li><li><a href="javascript:;" class="reportSpam_user">举报</a></li></ul></div></div><div class="profile_box_users"><div style="display:none" class="usersList similarUser_list head-list"></div><script>seajs.use('SNB.similarUsers.js', function(){
  var collection=new SNB.Collections.similarUsers();
  collection.fetch({
    success:function(){
      var col_length = collection.length;
      if(col_length){
        var views=new SNB.Views.similarUsersList({el:$(".similarUser_list"),collection:collection});
        views.render();
        $(".similarUser_list").prepend("<h3>兴趣相近</h3>").show();
      }
    }
  })
})</script></div></div><div class="profile_box_info"><div class="profile_info"><div class="profile_info_pic"><img src="http://xavatar.imedao.com/community/201210/1352439404964-20121221.png!100x100.png" width="100" height="100"/></div><div class="profile_info_content"><h2><span>zangyn</span><a href="＃" style="display:none" data-user-id='6785033954' data-user-name="zangyn" class="setRemark">(备注)</a></h2><script>seajs.use("SNB.base.js", function(){
  SNB.get("/user/profile/show.json", {uid: SNB.profileUser.id, property: "card_sid,personality"}, function(data) {
    $(".profile_info_content h2").append("<a target='_blank' title='雪球名片' style='margin-left:6px' href='" + SNB.profileUser.profile + "/card'><img title='雪球名片' src='http://assets.imedao.com/images/card/" + (data[0]?'namecard-icon2.png':'namecard-icon2-gray.png') + "'/></a>")
    var p = data[1] && data[1].value != 'false';
    $(".profile_info_content h2").append("<a target='_blank' title='投资者性格" + (p ? '：' + SNB.Util.personalityResult(data[1].value) : '') + "' style='margin-left:6px' href='/event/personality/x/" + (SNB.profileUser.domain || SNB.profileUser.id) + "'><img title='投资者性格" + (p ? '：' + SNB.Util.personalityResult(data[1].value) : '') + "' src='http://assets.imedao.com/images/personality/icon_character" + (p ? '' : '_gray') + ".png'/></a>")
  })
})</script><ul><li class="gender_info"><span class="m head"></span>男&nbsp;&nbsp;&nbsp;海外澳大利亚&nbsp;&nbsp;&nbsp;</li><li>股票130只&nbsp;&nbsp;讨论7506条&nbsp;&nbsp;粉丝200893人</li><li><div class="item_title">能力圈：</div><div class="item_content discuss_stock_list"><span title="科大讯飞" class="discuss_stock">科大讯飞，</span><span title="中国平安" class="discuss_stock">中国平安，</span><span title="中信证券" class="discuss_stock">中信证券</span></div></li><li><div class="item_title">简介：</div><div class="item_content expend_in_oneline"><p class="summary">如果不上雪球，你就输在了投资的起跑线上。</p><p style="display:none" class="detail">如果不上雪球，你就输在了投资的起跑线上。<span class="fold_all">收起<i class="newIcon_expend"></i></span></p></div></li></ul></div></div><script>seajs.use("SNB.base.js", function(){
  SNB.get("/account/oauth/user/show.json",{source:"sina",userid:SNB.profileUser.id},function(ret){
    if(ret && ret.id){
      $(".profile_info").find("ul li").eq(0).append("<a href='http://weibo.com/"+ret.id+"' target='_blank'><span class='newIcon newIcon_weibo'>&nbsp;</span> 微博</a>")
    }
  })
  $(".show_all,.fold_all").on("click",function(e){
    e.preventDefault();
    var that = this;
    $(that).closest(".expend_in_oneline").find("p").toggle();
  })
})</script></div></div><link rel="stylesheet" href="http://assets.imedao.com/style/pages/invest/profile_broker_rank-55a18e.css"><div class="rank-container"><div class="rank-groups newtab"><ul class="nav nav-tabs rank-tabs"></ul><span class="desc">每天的数据将于第二个交易日13:00前更新，由用户及<a href="http://bj.cgws.com/Default.jsp" target="_blank">长城证券</a>授权提供。</span><a href="http://xueqiu.com/3945550771/31966036" class="link">榜单说明</a><a href="http://xueqiu.com/event/rank/gws" class="link">看看其他人</a></div><div class="rank-wrapper"><div class="rank-performance"><div class="performance-title"><span class="title">账户收益</span></div><div class="performance-chart"><div class="performance-info"><div class="performance-income"><div id="pchart"></div><div class="performance-rate"><p class="desc">参赛后的收益率</p><p class="income"> </p><p class="time">参赛时间：-</p><div class="rank-stocks"><p><span class="title">持股前五：</span></p></div></div></div><div class="rank-hold"><div class="rank-day-rate"><p class="data">-</p><p class="desc">日收益</p></div><div class="rank-assets"><p class="data">-</p><p class="desc">净资产</p></div><div class="rank-marketValue"><p class="data">-</p><p class="desc">总市值</p></div><div class="rank-rate"><p class="data">-</p><p class="desc">持仓比例</p></div></div></div></div></div><div class="rank-chart"><div id="capitalReturnRateChartContainer" class="chartContainer"><div class="noData"><span>请您在券商处同步盈亏，或券商暂未支持同步。 </span></div><div class="head"><h3> <a href="/performance">收益率</a></h3><span class="timeInterval"></span><span class="dropdown"><span>业绩对比</span><span class="caret"></span></span></div><div id="ROAStateInfo" class="stateInfo"><span class="stockInfo"><span class="sign"></span><span class="stockName">盈亏 </span><span class="stockUp"></span></span><div class="loadState">数据载入中    </div></div><div id="capitalReturnRateChart"></div><div class="chartInfo"><ul class="selectTime"><li id="1m" class="selected">1月</li><li id="3m">3月</li><li id="6m">6月</li><li id="1y">1年</li><li id="3y">3年</li><li id="5y">5年</li><li id="all">全部</li></ul><span class="info">仅自己可见</span></div><div id="popCompare"><div class="popLeft"><label class="checkbox"> <input type="checkbox" symbol="SH000001"/>上证指数</label><label class="checkbox"> <input type="checkbox" symbol="SZ399001"/>深证指数</label><label class="checkbox"> <input type="checkbox" symbol="HKHSI"/>恒生指数</label><label class="checkbox"> <input type="checkbox" symbol="SP500"/>标准普尔500指数</label><label class="checkbox"> <input type="checkbox" symbol="NASDAQ"/>纳斯达克指数</label><label class="checkbox"> <input type="checkbox" symbol="DJI30"/>道琼斯指数</label><label class="checkbox"> <input type="checkbox" symbol="ICS30"/>i美股中概30指数</label><label class="checkbox"> <input type="checkbox" symbol=""/><input id="searchCompareStock" type="input" placeholder="股票名称/代码"/></label></div><div class="popRight"></div><div class="popClose"><button class="btn">关闭</button></div></div></div><div class="rank-industry"><div class="industry-title">行业分布</div><div class="industry-chart"></div></div></div><div class="rank-tran">   <div class="tran-title"><span class="title">交易历史</span><a href="#" class="show-trans">交易<span class="tran-num"></span>笔，点击查看</a></div><div class="tran-list"></div><div class="hide-tran-list"><a href="#">收起</a></div></div><div class="rank-status"><div class="status-title"><span class="title">关于"百度(BIDU)的讨论"</span><a href="#" class="back-trans">返回交易历史</a></div><div class="tran-status-list"></div></div></div></div><script src="http://assets.imedao.com/js/pages/invest/SNB.profile_broker_rank-85311d.js"></script><style>.cube-follow {
  text-decoration: none;
  cursor: pointer;
}

.cube-follow span {
  display: none;
  width: 20px;
  height: 12px;
  margin:0 3px;
}

.cube-follow-false .add {
  display: inline-block;
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat -18px -1px;
}

.cube-follow-true .del {
  display: inline-block;
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat  0px -1px;
}

a.rebalance {

  display: inline-block;
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat -60px 0px;
  width: 20px;
  height: 12px;
}
a.contact{
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat -40px 0px;
  display: inline-block;
  width: 20px;
  height: 12px;
}
.limit{
  background: none!important;
  width: auto!important;
  margin: 0!important;
  
}
.moreC{
  background: none;
  border: none;
  color: #0055A2;
  cursor: pointer;
  height: 20px;
  line-height: 20px;
  margin: 0;
  padding: 5px 6px 5px 15px;
  text-align: right;
  border-top: 1px solid #DDD;
}
.none{
  padding: 15px;
  font-size: 14px;
  text-align: center;
  color: #aaa;
}

</style><div class="profile-cube-list portfolioContainer"><div class="cube-title newtab"><ul style="float:left;display:block" class="nav nav-tabs"><li class="active"><a class="nav nav-tabs">他创建的组合(<i class="num">--</i>)</a></li></ul><div class="clear"></div></div><div class="tableContainer"><table><thead><tr><th>组合</th><th>最新净值</th><th>总收益</th><th width="87px">操作</th></tr></thead><tbody><tr><td colspan="4"><div class="loading"></div></td></tr></tbody></table></div></div><script>$.ajax({
  url:"/cubes/count_limit.json",
  data:{
    user_id:SNB.profileUser.id
  },
  type:"get"
}).success(function(data){
  $('.profile-cube-list .cube-title .num').text(data.exists_count);
  $('.profile-cube-list .cube-title .limit').text(data.allow_count);
  
})
seajs.use('cube/profile_cubes.js');
</script><div class="portfolioContainer"><div class="newtab"><ul id="portfolioTab" class="nav nav-tabs"></ul><div class="clear"></div></div><div class="tableContainer"><table class="portfolioNew"><thead><tr><th style="min-width:120px;">股票</th><th style="min-width:40px;">当前价 </th><th style="min-width:80px;">买入目标价</th><th style="min-width:80px;">卖出目标价</th><th>备注</th></tr></thead><tbody><tr><td colspan="7"><div class="loading"></div></td></tr></tbody></table></div></div><script src="http://assets.imedao.com/js/jquery.mousewheel-41ebd2.js"></script><script src="http://assets.imedao.com/js/raphael-ea1c64.js"></script><script>seajs.use('SNB.dialog.js')
seajs.use(['SNB.newChart.js', 'SNB.portfolioNew.js'],function(_c, p){
  var portfolio=new p.Portfolio();
})</script><div class="status_box "><div class="statuses_tab newtab"><ul class="nav nav-tabs"><li id="statusMenu" class="dropdown active status_tab"><a href="#status_content" data-target="#statusMenu" data-type="" data-toggle="dropdown" data-text="主贴(7506)">主贴<b class="caret"></b></a><ul class="dropdown-menu"><li><a href="#status_content" data-toggle="tab" data-type="" data-text="主贴">主贴</a></li><li><a href="#status_content" data-toggle="tab" data-type="0" data-text="原发布">原发布</a></li><li><a href="#status_content" data-toggle="tab" data-type="1" data-text="带标题">带标题</a></li><li><a href="#status_content" data-toggle="tab" data-type="2" data-text="长文章">长文章</a></li><li><a href="#status_content" data-toggle="tab" data-type="3" data-text="交易">交易</a></li></ul></li><li><a href="#favs_content" data-toggle="tab">收藏<small id="favsCount"></small></a></li><li><a href="#friends_content" data-toggle="tab">关注(647)</a></li><li><a href="#followers_content" data-toggle="tab">粉丝(200893)</a></li></ul></div><div class="statuses_container container tab-content"><div id="status_content" class="status_content container active tab-pane"><div class="status_bd"><div id="statusLists" class="allStatuses no-head"></div></div><div class="status_widget"><div class="seachbar"><input id="searchStatus" type="text" autocomplete="off" placeholder="搜索他的讨论" class="placeholder"/><span class="glass"><i></i></span></div><style>.mentionedStocks{
  margin-top:15px;
  display:none;
}
.stocksList{
  border-top:1px solid #F1F1F1;
  margin-top: 8px;
  padding-top: 10px;
  font-size:12px;
}
.stocksList .stockInfo{
  display:inline-block;
  margin-right:5px;
  margin-bottom:8px;
}
.stocksList .stockInfo span{
  color:#888;
  cursor:pointer;
}
</style><div class="mentionedStocks"><h2 class="widget-title">他经常讨论的股票 </h2><div class="fixit"></div><div class="stocksList"></div><div class="fixit"></div><script>seajs.use("SNB.base.js", function(){
  var uid = 6785033954;
  SNB.get("/user/top_status_count_stock.json", { count: 5, uid: uid }, function(stocks){
    if ( stocks && stocks.length ) {
      var html = "";
      _.each(stocks, function(stock, index){
        if ( stock.status_all_count > 0 ) {
          var count = stock.status_all_count,
            name = stock.stockName,
            symbol = stock.symbol,
            title = name + "(" + symbol + ") 查看" + count + "条讨论";
            
          html += '<span class="stockInfo" title="' + title + '" data-name="' + name + '" data-symbol="' + symbol + '" data-count="' + count + '"><a href="#">' + name + '</a><span>(<span class="status_count">' + count + '</span>条讨论)</span></span>';
        }
      });
      if ( html ) {
        $(".mentionedStocks .stocksList").append(html);
        $(".mentionedStocks").show();
      }
    }
  })
})</script></div></div></div><div id="favs_content" class="fade tab-pane"></div><div id="friends_content" class="fade tab-pane"></div><div id="followers_content" class="fade tab-pane"></div></div><style>.seachbar .glass {
  padding:0;
}
.seachbar .glass i{
  background-position:-172px -1px
}</style><script>(function($){
  SNB.data.req_isBrick = 0;
  SNB.data.statuses = {"total":7504,"maxPage":376,"count":20,"statuses":[{"id":23368339,"user_id":6785033954,"title":"社保基金抄底逃顶功夫精准 新进23股","created_at":1364135446000,"retweet_count":11,"reply_count":6,"fav_count":25,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"截至本周四收盘，两市已有569家(截至本周四晚间数据，下同)上市公司披露了2012年报，有332家公司净利润(母公司，下同)同比2011年实现正增长，占比为58.35%。新快报记者发现，向来以选股精准的社保基金，在去年四季度持有上述569家公司中的100家。该100家公司中，有67家去年业绩同比2011年录得增长...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23368339","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":660,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-24 22:30","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"截至本周四收盘，两市已有569家(截至本周四晚间数据，下同)上市公司披露了2012年报，有332家公司净利润(母公司，下同)同比2011年实现正增长，占比为58.35%。新快报记者发现，向来以选股精准的社保基金，在去年四季度持有上述569家公司中的100家。该100家公司中，有67家去年业绩同比2011年录得增长，占比为67%。今年以来，上述100家公司中，78家公司录得涨幅(前复权，下同)为正，占比高达78%。其中，涨幅最高的江山股份不到三个月涨幅已高达92.81%，几乎翻倍。此外，涨幅超10%的社保持有个股多达50家，而跌幅超10%的仅有5家，其中酒鬼酒今年跌22.16%，居社保持股涨幅榜倒数第一。以上数据显示，社保介入的个股，不论是业绩还是涨幅，整体表现非常良好。而考察其最近一期的新进及增持个股，从而了解社保的选股思路和操作风格等，将有助于普通投资者进行投资参考。<br>　　社保基金抄底逃顶功夫精准<br>　　在资本市场上，社保基金一向以操作稳健、善于抄底逃顶著称，其最经典的抄底逃顶案例莫过于于上证综指于2005年6月创下998点的历史大底时果断入场抄底，而在2007年&#34;5·30&#34;日前夕市场陷入一片疯狂时精准逃顶。社保基金最近的一次抄底发生在去年11月左右。据媒体报道，全国社保基金去年三季度以来已分多次对基金公司委托管理的社保组合进行增资，社保基金也因此在当年第三季度期间即对A股的低估值蓝筹板块展开&#34;抄底&#34;。报道还称，部分社保基金当时维持了较高的股票仓位。果然，市场的走势再度应证了社保眼光的精准。上证综指在去年12月4日创下1949.46点的低点之后，便一扫颓势，走出了一波约500点的强势逼空行情。<br>　　数据显示，社保基金自成立以来到2010年年底的累计投资收益额2772.60亿元，年均投资收益率9.17%。而由于权益投资一直保持了比较好的成绩，这几年，社保基金权益类投资的比例呈上升态势。2011年，社保基金投资收益率0.84%，虽低于往年，但仍录得正收益。2012年，社保基金投资收益率再度呈现高水准，达8.4%。<br>　　由于社保基金的投资业绩一向优良，关注其进出的个股，特别是最近一期的新进及增持个股，甚至与社保基金&#34;共进退&#34;，就不失为一种精明的投资策略了。截至本周四晚间的数据显示，在社保去年年末持有的100只个股中，社保基金新进了海翔药业、光线传媒等23家公司，增持了28家公司，减持了23家公司，对其余26家公司的持股数保持不变。<br>　　社保去年四季度新进23只个股<br>　　社保去年四季度新进的23只个股来自12个申万一级行业，其中以化工和机械设备板块的公司最多，两行业各有5家公司成为社保新宠。数据显示，该23家公司中，有18家公司去年业绩同比2011年实现正增长，其中业绩增长最低的为翰宇药业，录得增长11.59%。业绩增长最高的是江山股份，其去年实现净利润3332万元，同比2011年的505万元增长559.30%。此外，海翔药业、长园集团、四维图新、大连三垒和航天科技等5家公司去年业绩同比2011年录得下滑，其中海翔药业下滑最厉害，达78.32%，每股收益仅录得7分钱。今年以来，上述23只个股中，香雪股份等21只个股录得正收益，占比高达91.30%，其中江山股份涨幅最高，达92.81%；仅长园集团和丽江旅游录得负收益，但两者分别仅微跌0.32%和0.55%。和大盘今年的涨幅2.61%相比，该23只个股中有19只跑赢大盘，占比高达82.61%。而自去年12月4日市场见底以来，上述23只个股中，多达20股涨幅超19.8%，跑赢上证综指同期19.43%的涨幅。其中，江山股份涨幅最高，达152.17%，而光线传媒同期涨幅也超过了100%。同期，仅长园集团、丽江旅游、中国医药等3股跑输大盘。<br>　　持股比例方面，社保基金持有大连三垒178.12万股，占流通股比例为4.75%，在上述23只个股中持股比例最高。社保持股比例最小的是沧州大化，仅持有62.80万股，占流通股比例为0.24%。值得注意的是，在江山股份和海翔药业两只个股中，社保的持股比例分别为1.25%和0.89%，但两者在去年四季度末分别被QFII持有比例为1.32%和1.12%。<br>　　海油工程等28股获社保增持<br>　　去年四季度，社保基金增持了富春环保等28家公司。从增持股数与去年三季度末的持股数的比例来看，朗姿股份等15家公司获增持比例超50%，显示出社保对该类公司的喜爱。其中，法拉电子获增持幅度最大，达354.15%。社保持股数从去年三季末的107.92万股增加到去年四季度末的490.14万股，原持股的社保一零三组合加仓该股134.97万股，社保一零二组合则新进该股247.24万股。芜湖港获增持比例最低，仅为0.49%。从增持的股数来看，海油工程获增持股数最多，达1392.59万股，而荣盛发展和华侨城A获社保增持的股数也超1000万股。焦作万方获增持股数最少，仅为0.94万股。<br>　　数据显示，上述28家公司中，19家公司去年业绩同比2011年实现正增长，占比高达67.86%。其中，海油工程业绩增幅最大，达368.70%，而康得新去年业绩也比2011年增长超200%。莱宝高科等9家公司去年业绩负增长，其中焦作万方业绩下滑最厉害，比2011年下滑比例超100%。<br>　　今年以来，上述28只社保增持个股，有21家录得正收益，占比为75%。其中四川美丰涨幅最高，为60.55%。此外，荣盛发展、安徽合力等7只个股录得下跌，其中华侨城A跌幅最大，今年以来下跌18.80%。若从去年12月4日市场见底算起，仍为21只个股跑赢同期大盘的涨幅，其中乐视网涨幅最高，达102.01%，而经纬纺机等7股虽涨幅为正，但跑输同期大盘涨幅。<br>　　持股比例方面，社保基金持有重庆百货2623.89万股，占流通股比例为19.27%，在28家公司中持股比例最高。社保持股比例最小的个股为焦作万方，持股占流通股比例仅为0.30%。值得注意的是，在克明面业、朗姿股份和四川美丰三只个股中，社保分别持股178.34万股、293.63万股和699.26万股，同时QFII也分别持有38.55万股、197.05万股和291.20万股。<br>　　社保基金去年四季度新进个股一览<br>　　代码简称每股同比社保持股今年昨收<br>　　收益增长占流通股涨幅盘价<br>　　(元) (% ) 比例(% ) (% ) (元)<br>　　002621 大连三垒 0.38 -34.63 4.75 6.96 12.61<br>　　002405 四维图新 0.25 -48.85 2.76 15.26 13.52<br>　　300199 翰宇药业 0.45 11.59 1.49 59.54 22.00<br>　　600056 中国医药 1.12 29.50 1.39 8.12 21.83<br>　　300251 光线传媒 1.29 76.47 1.37 13.78 39.81<br>　　600389 江山股份 0.17 559.30 1.25 92.81 27.36<br>　　002033 丽江旅游 0.84 17.23 1.20 -0.55 18.00<br>　　000901 航天科技 0.16 -43.81 0.93 28.83 12.02<br>　　002099 海翔药业 0.07 -78.32 0.89 3.22 6.73<br>　　002145 中核钛白 0.00 100.93 0.81 8.48 12.02<br>　　600525 长园集团 0.25 -67.87 0.34 -0.32 6.30<br>　　600230 沧州大化 1.11 310.88 0.24 5.79 16.63<br>　　社保基金去年四季度增持个股一览<br>　　代码简称每股同比社保持股今年昨收<br>　　收益增长占流通股涨幅盘价<br>　　(元) (% ) 比例(% ) (% ) (元)<br>　　300104 乐视网 0.46 48.10 4.19 49.55 28.10<br>　　000731 四川美丰 0.60 6.19 1.39 60.55 11.64<br>　　002106 莱宝高科 0.20 -69.33 3.14 49.84 22.94<br>　　002450 康得新 0.68 223.49 3.75 34.69 32.73<br>　　002479 富春环保 0.32 22.87 2.37 37.28 17.16<br>　　000418 小天鹅A 0.54 -25.35 6.87 8.39 10.21<br>　　002661 克明面业 0.97 22.35 8.59 5.09 33.42<br>　　600563 法拉电子 1.08 -13.76 2.18 12.51 16.73<br>　　600583 海油工程 0.22 368.70 1.72 15.50 6.78<br>　　600729 重庆百货 1.87 15.29 19.27 -2.93 24.84<br>　　000026 飞亚达A 0.30 -19.06 3.29 -8.85 7.31<br>　　002146 荣盛发展 1.14 39.67 1.96 -2.07 13.70<br>　　000666 经纬纺机 0.61 -12.34 2.38 5.07 10.99<br>　　600575 芜湖港 0.32 18.69 5.78 11.53 7.93<br>　　000612 焦作万方 -0.03 -104.03 0.30 -7.76 9.99<br>　　002612 朗姿股份 1.16 10.85 5.06 -16.07 23.08<br>　　600761 安徽合力 0.68 -9.44 1.27 -3.69 8.61<br>　　000069 华侨城A 0.53 21.17 8.26 -18.80 6.09<br>　　注：文中社保持股公司数据截至到本周四晚间，行情数据等截至到本周五收盘。如无特别说明，文中其他数据均来自.","source":"雪球"},{"id":23362477,"user_id":6785033954,"title":"十八大新变化","created_at":1364048919000,"retweet_count":15,"reply_count":13,"fav_count":14,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"1、一把手眼镜摘了。 2、语速正常了。 3、普通话标准了。 4、第一夫人拿得出手了。 5、习主席、李总理，正读倒读都可以。 6、今年就业形势不容乐观，连常委都少招了两个。 7、常委都随老大习**脱西装、穿休闲装了。 8、 看看中国新一届领导班子名单，就知道马上要富强了：洗尽贫，立刻强，涨得奖，...","type":"1","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23362477","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":379,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-23 22:28","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"1、一把手眼镜摘了。<br> 2、语速正常了。<br>3、普通话标准了。<br> 4、第一夫人拿得出手了。<br>5、习主席、李总理，正读倒读都可以。<br>6、今年就业形势不容乐观，连常委都少招了两个。<br>7、常委都随老大习**脱西装、穿休闲装了。<br>8、 看看中国新一届领导班子名单，就知道马上要富强了：洗尽贫，立刻强，涨得奖，遇正升，留 运山，旺气山，涨高哩。<br>9、 上届 温+饱，这届 立刻强！","source":"雪球"},{"id":23362426,"user_id":6785033954,"title":"","created_at":1364048530000,"retweet_count":0,"reply_count":3,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> 如果反腐败都能成为一个股票重大利空的话，这个股票还适合长期投资吗？比如贵州茅台。。。","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23362426","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":333,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-23 22:22","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> 如果反腐败都能成为一个股票重大利空的话，这个股票还适合长期投资吗？比如贵州茅台。。。","source":"雪球"},{"id":23359616,"user_id":6785033954,"title":"机构看好环保板块长期走势，各路资金长线布局","created_at":1364015790000,"retweet_count":2,"reply_count":2,"fav_count":4,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"昨日，大盘呈现明显的震荡走势，环保股则高歌猛进。截至昨日收盘，环保行业上涨4.11%，领跑两市板块涨幅榜，首创股份、兴蓉投资、碧水源等再创反弹新高。 海通证券认为，综合环保行业的长期发展背景及历次5年周期的投资增速规律，2013年全年环保投资及企业盈利增长仍较为乐观。当前估值虽然处于较...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23359616","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":500,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-23 13:16","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"昨日，大盘呈现明显的震荡走势，环保股则高歌猛进。截至昨日收盘，环保行业上涨4.11%，领跑两市板块涨幅榜，首创股份、兴蓉投资、碧水源等再创反弹新高。<br><br> &nbsp;海通证券认为，综合环保行业的长期发展背景及历次5年周期的投资增速规律，2013年全年环保投资及企业盈利增长仍较为乐观。当前估值虽然处于较高水平，但那些具备持续成长性的行业龙头及存在业绩超预期可能的个股所出现的阶段调整，正是较好的投资机会。<br><br> &nbsp;环保红旗不倒<br><br> &nbsp;多股再创反弹新高<br><br> &nbsp;环保板块昨日全线飘红。创业环保和首创股份双双涨停，兴蓉投资、中原环保、碧水源等股涨幅逾6%。值得注意的是，首创股份、兴蓉投资、碧水源等股昨日均创出本轮反弹新高，创业环保、中原环保、龙净环保等股亦逼近前高。<br><br> &nbsp;从消息面来看，环保行业利好不断。环保部部长周生贤近日表示，环保部为防治PM2.5污染将出台一系列硬性措施。在全国两会上，国务院总理李**也明确表态，环境问题一是不能再欠新账，二要加快还旧账。全国两会公布的中央预算显示，2013年节能环保支出2101.27亿元，比上年预算增长18.8%，环保行业投资保持快速增长。<br><br> &nbsp;记者注意到，自去年12月4日反弹至今，环保板块累计涨幅高达66.12%，大幅跑赢同期大盘。在整个板块上涨的过程中，大气污染、水污染等突发性事件的出现，对相关子行业公司股价的刺激更是引人注目。各地大面积雾霾天气刺激空气治理相关个股走强，主营除尘的龙净环保和从事除尘滤袋生产的三维丝期间累计涨幅分别达118.47%、83.73%。涨幅同样可观的还有因山东地下水污染事件被曝光而受关注的水处理板块，其行业龙头首创股份和创业环保期间累计涨幅分别高达98.98%、151.22%。<br><br> &nbsp;王亚伟力捧环保<br><br> &nbsp;机构看好长期走势<br><br> &nbsp;据悉，已成立私募基金的王亚伟近日发表对股市的看法，表示非常看好环保股。王亚伟认为，环保是未来中国经济结构性转型的突破口，环保投资增速未来5年内将远高于GDP（国内生产总值）增速。而环保也是地方政府业绩考核指标之一，从上到下都重视的话，注定会带动全新的商业模式。<br><br> &nbsp;实际上，不但前公募一哥看好环保股，机构们的看法也高度一致。平安证券认为，节能环保投资增速低于过去5年平均水平主要源自结构调整，环保“十二五”规划已为未来环保高投入奠定基调，各类专项规划也有望陆续推出，环保行业投入高增长确定性强。虽然环保板块整体估值较高，有阶段性调整压力，但是行业高投入对高估值形成支撑，加上公众关注度提高，板块将保持较高估值水平，投资机会也将贯穿全年。<br><br> &nbsp;国金证券在环保行业年度报告中指出，在新届政府执政为民理念的贯彻下，关于环保产业的政策导向将持续向好。结合环保“十二五”规划看，行业空间巨大，而李**总理的讲话也明确了财政支出要更多向民生倾斜，这也将逐步消除之前市场对于环保投资资金来源的疑惑，未来的投资确定性也将持续增强。加上环保是目前市场为数不多景气度向上且不受宏观经济影响的行业，因此布局环保大方向没问题。","source":"雪球"},{"id":23359540,"user_id":6785033954,"title":"环保板块将复制前几年稀土板块的走势","created_at":1364014743000,"retweet_count":5,"reply_count":7,"fav_count":11,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SZ000598\"   target=\"_blank\">$兴蓉投资(SZ000598)$</a> 环保行业未来五年高景气，坚定看好，年报十送十，短期炒作的成分加大了一些，高换手率孕育着大机会，21日机构亿元资金高位建仓看来是奔着长线去的，放长远看环保行业中的优质股才相当于当时二三十元的包钢稀土。 介入环保是长线布局，选择兴蓉投资则是因为它在整个环保行业估...","type":"3","source_link":null,"edited_at":1364014922000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23359540","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":414,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-23 12:59","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SZ000598\"   target=\"_blank\">$兴蓉投资(SZ000598)$</a> 环保行业未来五年高景气，坚定看好，年报十送十，短期炒作的成分加大了一些，高换手率孕育着大机会，21日机构亿元资金高位建仓看来是奔着长线去的，放长远看环保行业中的优质股才相当于当时二三十元的包钢稀土。<br>介入环保是长线布局，选择兴蓉投资则是因为它在整个环保行业估值最低，又具有异地大肆扩张的能力。近期连续高换手后会有缩量上行的阶段，以后环保中的优质股怎么走，可以参照包钢稀土08年下半年到11年上半年的走势，可能强一些，可能会弱一些，但趋势是一样的。","source":"雪球"},{"id":23355735,"user_id":6785033954,"title":"","created_at":1363960954000,"retweet_count":0,"reply_count":1,"fav_count":1,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600436\"   target=\"_blank\">$片仔癀(SH600436)$</a> 片仔癀2012年中国医药企业500强资产总额排名第111名，利润总额排名第53名。","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23355735","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":283,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-22 22:02","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600436\"   target=\"_blank\">$片仔癀(SH600436)$</a> 片仔癀2012年中国医药企业500强资产总额排名第111名，利润总额排名第53名。","source":"雪球"},{"id":23355671,"user_id":6785033954,"title":"","created_at":1363960783000,"retweet_count":0,"reply_count":0,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600535\"   target=\"_blank\">$天士力(SH600535)$</a> 天士力2012年中国医药企业500强资产总额排名第五名，利润总额排名第八名。","type":"0","source_link":null,"edited_at":1363960800000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23355671","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":285,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-22 21:59","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600535\"   target=\"_blank\">$天士力(SH600535)$</a> 天士力2012年中国医药企业500强资产总额排名第五名，利润总额排名第八名。","source":"雪球"},{"id":23355650,"user_id":6785033954,"title":"","created_at":1363960612000,"retweet_count":2,"reply_count":10,"fav_count":4,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/PRE317\"   target=\"_blank\">$中信国健(PRE317)$</a> 中信国健2012年利润3亿左右，2012年中国医药企业资产总额排名116名，利润总额排名65名。","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23355650","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":340,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-22 21:56","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/PRE317\"   target=\"_blank\">$中信国健(PRE317)$</a> 中信国健2012年利润3亿左右，2012年中国医药企业资产总额排名116名，利润总额排名65名。","source":"雪球"},{"id":23355548,"user_id":6785033954,"title":"2012年中国医药企业500强（按利润总额）完全榜单","created_at":1363960067000,"retweet_count":27,"reply_count":13,"fav_count":66,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"2012年中国医药企业500强完全榜单 （按利润总额） 排名 企业名称 1 威高集团有限公司 2 扬子江药业集团有限公司 3 山东步长制药股份有限公司 4 中国医药集团总公司 5 齐鲁制药有限公司 6 修正药业集团股份有限公司 7 新和成控股集团有限公司 8 天津天士力集团有限公司 9 广州医药集团有限公司 10 ...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23355548","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":36064,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-22 21:47","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"2012年中国医药企业500强完全榜单<br><br>（按利润总额）<br><br>排名 &nbsp;企业名称<br><br>1 &nbsp;威高集团有限公司<br><br>2 &nbsp;扬子江药业集团有限公司<br><br>3 &nbsp;山东步长制药股份有限公司<br><br>4 &nbsp;中国医药集团总公司<br><br>5 &nbsp;齐鲁制药有限公司<br><br>6 &nbsp;修正药业集团股份有限公司<br><br>7 &nbsp;新和成控股集团有限公司<br><br>8 &nbsp;天津天士力集团有限公司<br><br>9 &nbsp;广州医药集团有限公司<br><br>10 赛诺菲(杭州)制药有限公司<br><br>11 江苏恒瑞医药股份有限公司<br><br>12 四川科伦药业股份有限公司<br><br>13 山东东阿阿胶股份有限公司<br><br>14 北京四环制药有限公司<br><br>15 江苏豪森医药集团有限公司<br><br>16 辉瑞制药有限公司<br><br>17 江苏正大天晴药业股份有限公司<br><br>18 浙江医药股份有限公司<br><br>19 费森尤斯卡比（中国）投资有限公司<br><br>20 辅仁药业集团有限公司<br><br>21 石药集团有限公司<br><br>22 鲁南制药集团股份有限公司<br><br>23 山东绿叶制药集团有限公司<br><br>24 哈药集团有限公司<br><br>25 中美天津史克制药有限公司<br><br>26 神威药业集团有限公司<br><br>27 华润双鹤药业股份有限公司<br><br>28 北京泰德制药股份有限公司<br><br>29 杭州华东医药集团有限公司<br><br>30 深圳市海普瑞药业股份有限公司<br><br>31 深圳信立泰药业股份有限公司<br><br>32 吉林敖东药业集团股份有限公司<br><br>33 葵花药业集团股份有限公司<br><br>34 天津中新药业集团股份有限公司<br><br>35 武汉人福医药集团股份有限公司<br><br>36 拜耳医药保健有限公司<br><br>37 上海罗氏制药有限公司<br><br>38 北京同仁堂健康药业股份有限公司<br><br>39 辽宁成大生物股份有限公司<br><br>40 丽珠医药集团股份有限公司<br><br>41 北京双鹭药业股份有限公司<br><br>42 山东罗欣药业股份有限公司<br><br>43 广西梧州制药(集团)股份有限公司<br><br>44 中国远大集团有限责任公司<br><br>45 康恩贝集团有限公司<br><br>46 西安万隆制药股份有限公司<br><br>47 乐普(北京）医疗器械股份有限公司<br><br>48 仁和（集团）发展有限公司<br><br>49 微创医疗器械（上海）有限公司<br><br>50 桂林三金药业股份有限公司<br><br>51 阿斯利康制药有限公司<br><br>52 瑞阳制药有限公司<br><br>53 漳州片仔癀药业股份有限公司<br><br>54 四川禾润制药有公司<br><br>55 浙江华海药业股份有限公司<br><br>56 惠氏制药有限公司<br><br>57 诺和诺德(中国)制药有限公司<br><br>58 江苏康缘集团有限责任公司<br><br>59 牡丹江友搏药业股份有限公司<br><br>60 珠海联邦制药股份有限公司<br><br>61 江西济民可信集团有限公司<br><br>62 辰欣药业股份有限公司<br><br>63 江苏济川制药有限公司<br><br>64 天津力生制药股份有限公司<br><br>65 上海中信国健药业有限公司<br><br>66 青岛黄海制药有限责任公司<br><br>67 锦州奥鸿药业有限责任公司<br><br>68 华方医药科技有限公司<br><br>69 北京同仁堂科技发展股份有限公司<br><br>70 西安利君制药有限责任公司<br><br>71 浙江海正药业股份有限公司<br><br>72 长春金赛药业股份有限公司<br><br>73 江苏奥赛康药业股份有限公司<br><br>74 黑龙江江世药业有限公司<br><br>75 四川好医生药业集团有限公司<br><br>76 上海第一生化药业有限公司<br><br>77 上海凯宝药业股份有限公司<br><br>78 西安力邦制药有限公司<br><br>79 上海莱士血液制品股份有限公司<br><br>80 吉林省都邦药业股份有限公司<br><br>81 江中药业股份有限公司<br><br>82 寿光富康制药有限公司<br><br>83 吉林金宝药业股份有限公司<br><br>84 北京紫竹药业有限公司<br><br>85 南京医药产业（集团）有限责任公司<br><br>86 宜昌东阳光药业股份有限公司<br><br>87 上海中西三维药业有限公司<br><br>88 山东淄博山川医用器材有限公司<br><br>89 广东一方制药有限公司<br><br>90 辽宁依生生物制药有限公司<br><br>91 山东达因海洋生物制药股份有限公司<br><br>92 沈阳三生制药有限责任公司<br><br>93 北京嘉林药业股份有限公司<br><br>94 通用电气药业（上海）有限公司<br><br>95 浙江尖峰集团股份有限公司<br><br>96 海南卫康制药（潜山）有限公司<br><br>97 江苏亚邦药业集团股份有限公司<br><br>98 上海强生制药有限公司<br><br>99 山东睿鹰先锋制药有限公司<br><br>100 &nbsp;&nbsp;&nbsp;贵州泰邦生物制品有限公司<br><br>101 &nbsp;&nbsp;&nbsp;石家庄以岭药业股份有限公司<br><br>102 &nbsp;&nbsp;&nbsp;正大青春宝药业有限公司<br><br>103 &nbsp;&nbsp;&nbsp;西安杨森制药有限公司<br><br>104 &nbsp;&nbsp;&nbsp;四川百利药业有限责任公司<br><br>105 &nbsp;&nbsp;&nbsp;广东众生药业股份有限公司<br><br>106 &nbsp;&nbsp;&nbsp;紫光古汉集团股份有限公司<br><br>107 &nbsp;&nbsp;&nbsp;山西康宝生物制品股份有限公司<br><br>108 &nbsp;&nbsp;&nbsp;赛诺菲（北京）制药有限公司<br><br>109 &nbsp;&nbsp;&nbsp;四川省百草生物药业有限公司<br><br>110 &nbsp;&nbsp;&nbsp;天津红日药业股份有限公司<br><br>111 &nbsp;&nbsp;&nbsp;贵州益佰制药股份有限公司<br><br>112 &nbsp;&nbsp;&nbsp;健康元药业集团股份有限公司<br><br>113 &nbsp;&nbsp;&nbsp;哈尔滨誉衡药业股份有限公司<br><br>114 &nbsp;&nbsp;&nbsp;百泰生物药业有限公司<br><br>115 &nbsp;&nbsp;&nbsp;成都康弘药业集团<br><br>116 &nbsp;&nbsp;&nbsp;雅安三九药业有限公司<br><br>117 &nbsp;&nbsp;&nbsp;山东齐都药业有限公司<br><br>118 &nbsp;&nbsp;&nbsp;珠海亿邦制药股份有限公司<br><br>119 &nbsp;&nbsp;&nbsp;常州千红生化制药有限公司<br><br>120 &nbsp;&nbsp;&nbsp;江西青峰药业有限公司<br><br>121 &nbsp;&nbsp;&nbsp;江苏苏中药业集团股份有限公司<br><br>122 &nbsp;&nbsp;&nbsp;珠海安生医药有限公司<br><br>123 &nbsp;&nbsp;&nbsp;河南省宛西制药股份有限公司<br><br>124 &nbsp;&nbsp;&nbsp;卫材（中国）药业有限公司<br><br>125 &nbsp;&nbsp;&nbsp;浙江仙琚制药股份有限公司<br><br>126 &nbsp;&nbsp;&nbsp;黑龙江天宏药业有限公司<br><br>127 &nbsp;&nbsp;&nbsp;贵州拜特制药有限公司<br><br>128 &nbsp;&nbsp;&nbsp;山东方明药业集团股份有限公司<br><br>129 &nbsp;&nbsp;&nbsp;成都地奥制药集团有限公司<br><br>130 &nbsp;&nbsp;&nbsp;悦康药业集团有限公司<br><br>131 &nbsp;&nbsp;&nbsp;甘李药业有限公司<br><br>132 &nbsp;&nbsp;&nbsp;吉林万通药业集团梅河药业股份有限公司<br><br>133 &nbsp;&nbsp;&nbsp;苏州百特医疗用品有限公司<br><br>134 &nbsp;&nbsp;&nbsp;北京同仁堂健康药业(福州)有限公司<br><br>135 &nbsp;&nbsp;&nbsp;山东省药用玻璃股份有限公司<br><br>136 &nbsp;&nbsp;&nbsp;康臣药业(内蒙古)有限责任公司<br><br>137 &nbsp;&nbsp;&nbsp;海南海药股份有限公司<br><br>138 &nbsp;&nbsp;&nbsp;上海昊海生物科技有限公司<br><br>139 &nbsp;&nbsp;&nbsp;四川禾邦阳光制药股份有限公司<br><br>140 &nbsp;&nbsp;&nbsp;浙江天皇药业有限公司<br><br>141 &nbsp;&nbsp;&nbsp;长春长生生物科技股份有限公司<br><br>142 &nbsp;&nbsp;&nbsp;上海中西制药有限公司<br><br>143 &nbsp;&nbsp;&nbsp;苏州东瑞制药有限公司<br><br>144 &nbsp;&nbsp;&nbsp;天圣制药集团股份有限公司<br><br>145 &nbsp;&nbsp;&nbsp;北京九强生物技术有限公司<br><br>146 &nbsp;&nbsp;&nbsp;中美上海施贵宝制药有限公司<br><br>147 &nbsp;&nbsp;&nbsp;山西普德药业股份有限公司<br><br>148 &nbsp;&nbsp;&nbsp;江苏恩华药业股份有限公司<br><br>149 &nbsp;&nbsp;&nbsp;贵州百灵企业集团制药股份有限公司<br><br>150 &nbsp;&nbsp;&nbsp;北京赛科药业有限责任公司<br><br>151 &nbsp;&nbsp;&nbsp;常州四药制药有限公司<br><br>152 &nbsp;&nbsp;&nbsp;北京赛升药业股份有限公司<br><br>153 &nbsp;&nbsp;&nbsp;江西普正制药有限公司<br><br>154 &nbsp;&nbsp;&nbsp;河南福森药业有限公司<br><br>155 &nbsp;&nbsp;&nbsp;株洲千金药业股份有限公司<br><br>156 &nbsp;&nbsp;&nbsp;重庆药友制药有限责任公司<br><br>157 &nbsp;&nbsp;&nbsp;九芝堂股份有限公司<br><br>158 &nbsp;&nbsp;&nbsp;四川大千药业有限公司<br><br>159 &nbsp;&nbsp;&nbsp;上海景峰制药股份有限公司<br><br>160 &nbsp;&nbsp;&nbsp;天津金耀集团有限公司<br><br>161 &nbsp;&nbsp;&nbsp;普洛股份有限公司<br><br>162 &nbsp;&nbsp;&nbsp;中国通用技术（集团）控股有限责任公司<br><br>163 &nbsp;&nbsp;&nbsp;贵州同济堂制药有限公司<br><br>164 &nbsp;&nbsp;&nbsp;浙江永宁制药厂<br><br>165 &nbsp;&nbsp;&nbsp;深圳九新药业有限公司<br><br>166 &nbsp;&nbsp;&nbsp;浙江天宇药业股份有限公司<br><br>167 &nbsp;&nbsp;&nbsp;海南海灵化学制药有限公司<br><br>168 &nbsp;&nbsp;&nbsp;浙江中贝九洲集团有限公司<br><br>169 &nbsp;&nbsp;&nbsp;双鸽集团有限公司<br><br>170 &nbsp;&nbsp;&nbsp;深圳万乐药业有限公司<br><br>171 &nbsp;&nbsp;&nbsp;上海希迪制药有限公司<br><br>172 &nbsp;&nbsp;&nbsp;上海和黄药业有限公司<br><br>173 &nbsp;&nbsp;&nbsp;曼秀雷敦（中国）药业有限公司<br><br>174 &nbsp;&nbsp;&nbsp;河南新帅克制药股份有限公司<br><br>175 &nbsp;&nbsp;&nbsp;亚宝药业集团股份有限公司<br><br>176 &nbsp;&nbsp;&nbsp;重庆华邦制药有限公司<br><br>177 &nbsp;&nbsp;&nbsp;山东润泽制药有限公司<br><br>178 &nbsp;&nbsp;&nbsp;金宇保灵生物药品有限公司<br><br>179 &nbsp;&nbsp;&nbsp;北京协和制药二厂<br><br>180 &nbsp;&nbsp;&nbsp;江苏柯菲平医药有限公司<br><br>181 &nbsp;&nbsp;&nbsp;四川康定金珠制药有限责任公司<br><br>182 &nbsp;&nbsp;&nbsp;浙江国邦药业有限公司<br><br>183 &nbsp;&nbsp;&nbsp;回音必集团有限公司<br><br>184 &nbsp;&nbsp;&nbsp;昆明积大制药股份有限公司<br><br>185 &nbsp;&nbsp;&nbsp;吉林金泉宝山药业集团股份有限公司<br><br>186 &nbsp;&nbsp;&nbsp;海南灵康药业集团股份有限公司<br><br>187 &nbsp;&nbsp;&nbsp;山东福田药业有限公司<br><br>188 &nbsp;&nbsp;&nbsp;湖南湘药制药有限公司<br><br>189 &nbsp;&nbsp;&nbsp;昆明龙津药业股份有限公司<br><br>190 &nbsp;&nbsp;&nbsp;江苏吴中医药集团有限公司<br><br>191 &nbsp;&nbsp;&nbsp;深圳市海王生物工程股份有限公司<br><br>192 &nbsp;&nbsp;&nbsp;哈尔滨三联药业有限公司<br><br>193 &nbsp;&nbsp;&nbsp;滇虹药业集团股份有限公司<br><br>194 &nbsp;&nbsp;&nbsp;海南养生堂有限公司<br><br>195 &nbsp;&nbsp;&nbsp;北京康仁堂药业有限公司<br><br>196 &nbsp;&nbsp;&nbsp;北京韩美药品有限公司<br><br>197 &nbsp;&nbsp;&nbsp;广西金嗓子有限责任公司<br><br>198 &nbsp;&nbsp;&nbsp;江西汇仁药业有限公司<br><br>199 &nbsp;&nbsp;&nbsp;重庆福安药业（集团）股份有限公司<br><br>200 &nbsp;&nbsp;&nbsp;百特（中国）投资有限公司<br><br>201 &nbsp;&nbsp;&nbsp;楚天科技股份有限公司<br><br>202 &nbsp;&nbsp;&nbsp;集安益盛药业股份有限公司<br><br>203 &nbsp;&nbsp;&nbsp;湖南恒生制药股份有限公司<br><br>204 &nbsp;&nbsp;&nbsp;深圳翰宇药业股份有限公司<br><br>205 &nbsp;&nbsp;&nbsp;诺维信（中国）生物技术有限公司<br><br>206 &nbsp;&nbsp;&nbsp;广西桂林中族中药股份有限公司<br><br>207 &nbsp;&nbsp;&nbsp;华仁药业股份有限公司<br><br>208 &nbsp;&nbsp;&nbsp;广州市香雪制药股份有限公司<br><br>209 &nbsp;&nbsp;&nbsp;浙江莎普爱思药业股份有限公司<br><br>210 &nbsp;&nbsp;&nbsp;广东太安堂药业股份有限公司<br><br>211 &nbsp;&nbsp;&nbsp;山西振东制药股份有限公司<br><br>212 &nbsp;&nbsp;&nbsp;大理药业股份有限公司<br><br>213 &nbsp;&nbsp;&nbsp;迪沙药业集团有限公司<br><br>214 &nbsp;&nbsp;&nbsp;辽宁诺康生物制药有限责任公司<br><br>215 &nbsp;&nbsp;&nbsp;上海信谊药厂有限公司<br><br>216 &nbsp;&nbsp;&nbsp;华北制药集团有限责任公司<br><br>217 &nbsp;&nbsp;&nbsp;泰尔茂医疗产品(杭州)有限公司<br><br>218 &nbsp;&nbsp;&nbsp;山东齐发药业有限公司<br><br>219 &nbsp;&nbsp;&nbsp;四川逢春制药有限公司<br><br>220 &nbsp;&nbsp;&nbsp;通化万通药业股份有限公司<br><br>221 &nbsp;&nbsp;&nbsp;东宝实业集团有限公司<br><br>222 &nbsp;&nbsp;&nbsp;南京圣和药业有限公司<br><br>223 &nbsp;&nbsp;&nbsp;湖南康源制药有限公司<br><br>224 &nbsp;&nbsp;&nbsp;汕头市超声仪器研究所有限公司<br><br>225 &nbsp;&nbsp;&nbsp;山东凤凰制药股份有限公司<br><br>226 &nbsp;&nbsp;&nbsp;湖南汉森制药股份有限公司<br><br>227 &nbsp;&nbsp;&nbsp;云南生物谷药业股份有限公司<br><br>228 &nbsp;&nbsp;&nbsp;北京绿竹生物制药有限公司<br><br>229 &nbsp;&nbsp;&nbsp;广东台城制药股份有限公司<br><br>230 &nbsp;&nbsp;&nbsp;北京万泰生物药业股份有限公司<br><br>231 &nbsp;&nbsp;&nbsp;海南亚洲制药有限公司<br><br>232 &nbsp;&nbsp;&nbsp;江苏万邦生化医药股份有限公司<br><br>233 &nbsp;&nbsp;&nbsp;宁波戴维医疗器械有限公司<br><br>234 &nbsp;&nbsp;&nbsp;云南白药集团文山七花有限责任公司<br><br>235 &nbsp;&nbsp;&nbsp;江西青春康源制药有限公司<br><br>236 &nbsp;&nbsp;&nbsp;福建三爱药业有限公司<br><br>237 &nbsp;&nbsp;&nbsp;东软飞利浦医疗设备系统有限责任公司<br><br>238 &nbsp;&nbsp;&nbsp;甘肃独一味生物制药股份有限公司<br><br>239 &nbsp;&nbsp;&nbsp;北大国际医院集团西南合成制药股份有限公司<br><br>240 &nbsp;&nbsp;&nbsp;沈阳双鼎制药有限公司<br><br>241 &nbsp;&nbsp;&nbsp;湖南千山制药机械股份有限公司<br><br>242 &nbsp;&nbsp;&nbsp;帝斯曼维生素（上海）有限公司<br><br>243 &nbsp;&nbsp;&nbsp;深圳市卫武光明生物制品有限公司<br><br>244 &nbsp;&nbsp;&nbsp;英科新创（厦门）科技有限公司<br><br>245 &nbsp;&nbsp;&nbsp;江西博雅生物制药股份有限公司<br><br>246 &nbsp;&nbsp;&nbsp;哈尔滨派斯菲科生物制药股份有限公司<br><br>247 &nbsp;&nbsp;&nbsp;北京天新福医疗器材有限公司<br><br>248 &nbsp;&nbsp;&nbsp;湘北威尔曼制药股份有限公司<br><br>249 &nbsp;&nbsp;&nbsp;罗赛洛(广东)明胶有限公司<br><br>250 &nbsp;&nbsp;&nbsp;北京诺华制药有限公司<br><br>251 &nbsp;&nbsp;&nbsp;北京协和药厂<br><br>252 &nbsp;&nbsp;&nbsp;吉林省辉南长龙生化药业股份有限公司<br><br>253 &nbsp;&nbsp;&nbsp;云南盘龙云海药业有限公司<br><br>254 &nbsp;&nbsp;&nbsp;天津华津制药有限公司<br><br>255 &nbsp;&nbsp;&nbsp;大冢（中国）投资有限公司<br><br>256 &nbsp;&nbsp;&nbsp;江西益康医疗器械集团有限公司<br><br>257 &nbsp;&nbsp;&nbsp;天津市天成制药有限公司<br><br>258 &nbsp;&nbsp;&nbsp;广东恒健制药有限公司<br><br>259 &nbsp;&nbsp;&nbsp;成都天台山制药有限公司<br><br>260 &nbsp;&nbsp;&nbsp;精华制药集团股份有限公司<br><br>261 &nbsp;&nbsp;&nbsp;上海康德莱企业发展集团股份有限公司<br><br>262 &nbsp;&nbsp;&nbsp;湖南尔康制药有限公司<br><br>263 &nbsp;&nbsp;&nbsp;上海强生有限公司<br><br>264 &nbsp;&nbsp;&nbsp;北京北陆药业股份有限公司<br><br>265 &nbsp;&nbsp;&nbsp;江西药都医药集团股份有限公司<br><br>266 &nbsp;&nbsp;&nbsp;广东太阳神集团有限公司<br><br>267 &nbsp;&nbsp;&nbsp;湖南洞庭药业股份有限公司<br><br>268 &nbsp;&nbsp;&nbsp;海口奇力制药股份有限公司<br><br>269 &nbsp;&nbsp;&nbsp;上海其胜生物制剂有限公司<br><br>270 &nbsp;&nbsp;&nbsp;施维雅（天津）制药有限公司<br><br>271 &nbsp;&nbsp;&nbsp;浙江圣达药业有限公司<br><br>272 &nbsp;&nbsp;&nbsp;安徽协和成药业饮片有限公司<br><br>273 &nbsp;&nbsp;&nbsp;浙江万邦药业有限公司<br><br>274 &nbsp;&nbsp;&nbsp;宁波立华制药有限公司<br><br>275 &nbsp;&nbsp;&nbsp;哈尔滨仁皇药业有限公司<br><br>276 &nbsp;&nbsp;&nbsp;江苏联环药业集团有限公司<br><br>277 &nbsp;&nbsp;&nbsp;广东环球制药有限公司<br><br>278 &nbsp;&nbsp;&nbsp;本溪龙宝(集团)参茸有限公司<br><br>279 &nbsp;&nbsp;&nbsp;宁夏泰瑞制药股份有限公司<br><br>280 &nbsp;&nbsp;&nbsp;广东彼迪药业有限公司<br><br>281 &nbsp;&nbsp;&nbsp;苏州二叶制药有限公司<br><br>282 &nbsp;&nbsp;&nbsp;珍奥集团股份有限公司<br><br>283 &nbsp;&nbsp;&nbsp;湖南方盛制药股份有限公司<br><br>284 &nbsp;&nbsp;&nbsp;浙江佐力药业股份有限公司<br><br>285 &nbsp;&nbsp;&nbsp;梅河口四环制药有限公司<br><br>286 &nbsp;&nbsp;&nbsp;湖北新生源生物工程股份有限公司<br><br>287 &nbsp;&nbsp;&nbsp;湖南泰尔制药股份有限公司<br><br>288 &nbsp;&nbsp;&nbsp;重庆正川玻璃有限公司<br><br>289 &nbsp;&nbsp;&nbsp;浙江天新药业有限公司<br><br>290 &nbsp;&nbsp;&nbsp;浙江贝达药业有限公司<br><br>291 &nbsp;&nbsp;&nbsp;瑞普（保定）生物药业有限公司<br><br>292 &nbsp;&nbsp;&nbsp;北京博士伦眼睛护理产品有限公司<br><br>293 &nbsp;&nbsp;&nbsp;吉林省通化振国药业有限公司<br><br>294 &nbsp;&nbsp;&nbsp;浙江司太立制药股份有限公司<br><br>295 &nbsp;&nbsp;&nbsp;浙江我武生物科股份有限公司<br><br>296 &nbsp;&nbsp;&nbsp;浙江新光药业有限公司<br><br>297 &nbsp;&nbsp;&nbsp;贵州健兴药业有限公司<br><br>298 &nbsp;&nbsp;&nbsp;珠海亿胜生物制药有限公司<br><br>299 &nbsp;&nbsp;&nbsp;浙江昂利康制药有限公司<br><br>300 &nbsp;&nbsp;&nbsp;浙江亚峰药厂有限公司<br><br>301 &nbsp;&nbsp;&nbsp;山东福胶集团有限公司<br><br>302 &nbsp;&nbsp;&nbsp;云南广泰生物科技开发公司<br><br>303 &nbsp;&nbsp;&nbsp;湖州数康生物科技有限公司<br><br>304 &nbsp;&nbsp;&nbsp;宁波人健药业集团股份有限公司<br><br>305 &nbsp;&nbsp;&nbsp;丹东医创药业有限责任公司<br><br>306 &nbsp;&nbsp;&nbsp;广西源安堂药业有限公司<br><br>307 &nbsp;&nbsp;&nbsp;海南惠普森医药生物技术有限公司<br><br>308 &nbsp;&nbsp;&nbsp;上海联合赛尔生物工程有限公司<br><br>309 &nbsp;&nbsp;&nbsp;广东华润顺峰药业有限公司<br><br>310 &nbsp;&nbsp;&nbsp;云南良方制药有限公司<br><br>311 &nbsp;&nbsp;&nbsp;山东新华医药集团有限责任公司<br><br>312 &nbsp;&nbsp;&nbsp;贵州景峰注射剂有限公司<br><br>313 &nbsp;&nbsp;&nbsp;山东宏济堂制药集团有限公司<br><br>314 &nbsp;&nbsp;&nbsp;黑龙江迪龙制药有限公司<br><br>315 &nbsp;&nbsp;&nbsp;杭州澳亚生物技术有限公司<br><br>316 &nbsp;&nbsp;&nbsp;海南中化联合制药工业有公司<br><br>317 &nbsp;&nbsp;&nbsp;上海天伟生物制药有限公司<br><br>318 &nbsp;&nbsp;&nbsp;四川升和药业股份有限公司<br><br>319 &nbsp;&nbsp;&nbsp;云南盟生药业有限公司<br><br>320 &nbsp;&nbsp;&nbsp;浙江升华拜克生物股份有限公司<br><br>321 &nbsp;&nbsp;&nbsp;湖南金沙药业有限责任公司<br><br>322 &nbsp;&nbsp;&nbsp;吉林紫鑫药业股份有限公司<br><br>323 &nbsp;&nbsp;&nbsp;山东三九药业有限公司<br><br>324 &nbsp;&nbsp;&nbsp;山东中保康医疗器具有限公司<br><br>325 &nbsp;&nbsp;&nbsp;江西三鑫医疗科技股份有限公司<br><br>326 &nbsp;&nbsp;&nbsp;吉林天强制药有限公司<br><br>327 &nbsp;&nbsp;&nbsp;山东仙河药业有限公司<br><br>328 &nbsp;&nbsp;&nbsp;上海绿谷制药有限公司<br><br>329 &nbsp;&nbsp;&nbsp;沈阳红旗制药有限公司<br><br>330 &nbsp;&nbsp;&nbsp;广西金嗓子药业股份有限公司<br><br>331 &nbsp;&nbsp;&nbsp;湖南华纳大药厂有限公司<br><br>332 &nbsp;&nbsp;&nbsp;山东华鲁制药有限公司<br><br>333 &nbsp;&nbsp;&nbsp;北京华素制药股份有限公司<br><br>334 &nbsp;&nbsp;&nbsp;上海旭东海普药业有限公司<br><br>335 &nbsp;&nbsp;&nbsp;贵州百花医药股份有限公司<br><br>336 &nbsp;&nbsp;&nbsp;上海益生源药业有限公司<br><br>337 &nbsp;&nbsp;&nbsp;上海医疗器械（集团）有限公司手术器械厂<br><br>338 &nbsp;&nbsp;&nbsp;浙江车头制药有限公司<br><br>339 &nbsp;&nbsp;&nbsp;瑞声达听力技术（中国）有限公司<br><br>340 &nbsp;&nbsp;&nbsp;山东先声麦得津生物制药有限公司<br><br>341 &nbsp;&nbsp;&nbsp;四川奥邦药业有限公司<br><br>342 &nbsp;&nbsp;&nbsp;陕西康惠制药股份有限公司<br><br>343 &nbsp;&nbsp;&nbsp;宁波永新光学股份有限公司<br><br>344 &nbsp;&nbsp;&nbsp;湖北午时药业股份有限公司<br><br>345 &nbsp;&nbsp;&nbsp;四川迪康科技药业股份有限公司<br><br>346 &nbsp;&nbsp;&nbsp;泰普生物科学（中国）有限公司<br><br>347 &nbsp;&nbsp;&nbsp;烟台大洋制药有限公司<br><br>348 &nbsp;&nbsp;&nbsp;海南皇隆制药厂有限公司<br><br>349 &nbsp;&nbsp;&nbsp;北京同仁堂制药有限公司<br><br>350 &nbsp;&nbsp;&nbsp;广东立国制药有限公司<br><br>351 &nbsp;&nbsp;&nbsp;浙江省浦江县恩尔康胶囊有限公司<br><br>352 &nbsp;&nbsp;&nbsp;深圳立健药业有限公司<br><br>353 &nbsp;&nbsp;&nbsp;国药集团容生制药有限公司<br><br>354 &nbsp;&nbsp;&nbsp;南京臣功制药股份有限公司<br><br>355 &nbsp;&nbsp;&nbsp;武汉海特生物制药股份有限公司<br><br>356 &nbsp;&nbsp;&nbsp;福建广生堂药业有限公司<br><br>357 &nbsp;&nbsp;&nbsp;承德颈复康药业集团有限公司<br><br>358 &nbsp;&nbsp;&nbsp;空气化工产品气体（深圳)有限公司<br><br>359 &nbsp;&nbsp;&nbsp;横店集团家园化工有限公司<br><br>360 &nbsp;&nbsp;&nbsp;青岛国风药业股份有限公司<br><br>361 &nbsp;&nbsp;&nbsp;深圳市中核海得威生物科技有限公司<br><br>362 &nbsp;&nbsp;&nbsp;威特（湖南）药业有限公司<br><br>363 &nbsp;&nbsp;&nbsp;辽宁东方人药业有限公司<br><br>364 &nbsp;&nbsp;&nbsp;陇西一方制药有限公司<br><br>365 &nbsp;&nbsp;&nbsp;四川源基制药有限公司<br><br>366 &nbsp;&nbsp;&nbsp;天津市威曼生物材料有限公司<br><br>367 &nbsp;&nbsp;&nbsp;青海制药（集团）有限责任公司<br><br>368 &nbsp;&nbsp;&nbsp;哈尔滨一洲制药有限公司<br><br>369 &nbsp;&nbsp;&nbsp;南昌立健药业有限公司<br><br>370 &nbsp;&nbsp;&nbsp;潍坊盛泰药业有限公司<br><br>371 &nbsp;&nbsp;&nbsp;山东鑫泉医药有限公司<br><br>372 &nbsp;&nbsp;&nbsp;青岛正大海尔制药有限公司<br><br>373 &nbsp;&nbsp;&nbsp;上海复旦复华药业有限公司<br><br>374 &nbsp;&nbsp;&nbsp;安徽环球药业股份有限公司<br><br>375 &nbsp;&nbsp;&nbsp;江西3L医用制品集团股份有限公司<br><br>376 &nbsp;&nbsp;&nbsp;贵州益康制药有限公司<br><br>377 &nbsp;&nbsp;&nbsp;江西昌诺药业有限公司<br><br>378 &nbsp;&nbsp;&nbsp;广西玉林制药集团有限责任公司<br><br>379 &nbsp;&nbsp;&nbsp;山西广生医药包装股份有限公司<br><br>380 &nbsp;&nbsp;&nbsp;云南鸿翔中药科技有限公司<br><br>381 &nbsp;&nbsp;&nbsp;陕西省汉王药业有限责任公司<br><br>382 &nbsp;&nbsp;&nbsp;杨凌东科麦迪森制药有限公司<br><br>383 &nbsp;&nbsp;&nbsp;重庆希尔安药业有限公司<br><br>384 &nbsp;&nbsp;&nbsp;浙江长生鸟药业有限公司<br><br>385 &nbsp;&nbsp;&nbsp;宁波鑫高益磁材有限公司<br><br>386 &nbsp;&nbsp;&nbsp;江西百神药业股份有限公司<br><br>387 &nbsp;&nbsp;&nbsp;重庆华森制药有限公司<br><br>388 &nbsp;&nbsp;&nbsp;西安环球印务股份有限公司<br><br>389 &nbsp;&nbsp;&nbsp;艾康生物技术（杭州）有限公司<br><br>390 &nbsp;&nbsp;&nbsp;北京利祥制药有限公司<br><br>391 &nbsp;&nbsp;&nbsp;上海执诚生物技术有限公司<br><br>392 &nbsp;&nbsp;&nbsp;山西云鹏制药有限公司<br><br>393 &nbsp;&nbsp;&nbsp;沈阳兴齐眼药股份有限公司<br><br>394 &nbsp;&nbsp;&nbsp;云南植物药业有限公司<br><br>395 &nbsp;&nbsp;&nbsp;金花企业（集团）股份有限公司<br><br>396 &nbsp;&nbsp;&nbsp;云南白药集团大理药业有限责任公司<br><br>397 &nbsp;&nbsp;&nbsp;浙江诚意药业有限公司<br><br>398 &nbsp;&nbsp;&nbsp;秦皇岛骊骅淀粉股份有限公司<br><br>399 &nbsp;&nbsp;&nbsp;内蒙古天奇中蒙制药股份有限公司<br><br>400 &nbsp;&nbsp;&nbsp;第一三共制药（北京）有限公司<br><br>401 &nbsp;&nbsp;&nbsp;陕西盘龙制药集团有限公司<br><br>402 &nbsp;&nbsp;&nbsp;海南双成药业股份有限公司<br><br>403 &nbsp;&nbsp;&nbsp;鲁南厚普制药有限公司<br><br>404 &nbsp;&nbsp;&nbsp;浙江天一堂药业有限公司<br><br>405 &nbsp;&nbsp;&nbsp;河北兴隆希力药业有限公司<br><br>406 &nbsp;&nbsp;&nbsp;浙江京新药业股份有限公司<br><br>407 &nbsp;&nbsp;&nbsp;贵阳新天药业股份有限公司<br><br>408 &nbsp;&nbsp;&nbsp;哈尔滨圣泰生物制药有限公司<br><br>409 &nbsp;&nbsp;&nbsp;桓仁巨户沟森涛山参基地<br><br>410 &nbsp;&nbsp;&nbsp;成都青山利康药业有限公司<br><br>411 &nbsp;&nbsp;&nbsp;福建南少林药业有限公司<br><br>412 &nbsp;&nbsp;&nbsp;诚达药业股份有限公司<br><br>413 &nbsp;&nbsp;&nbsp;美罗药业股份有限公司<br><br>414 &nbsp;&nbsp;&nbsp;桂林南药股份有限公司<br><br>415 &nbsp;&nbsp;&nbsp;重庆圣华曦药业有限公司<br><br>416 &nbsp;&nbsp;&nbsp;苏州天马医药集团有限公司<br><br>417 &nbsp;&nbsp;&nbsp;宜昌三峡制药有限公司<br><br>418 &nbsp;&nbsp;&nbsp;浙江新赛科药业有限公司<br><br>419 &nbsp;&nbsp;&nbsp;浙江伊宝馨生物科技股份有限公司<br><br>420 &nbsp;&nbsp;&nbsp;湖南九典制药有限公司<br><br>421 &nbsp;&nbsp;&nbsp;浙江康德莱医疗器械股份有限公司<br><br>422 &nbsp;&nbsp;&nbsp;四川省宜宾五粮液集团宜宾制药有限责任公司<br><br>423 &nbsp;&nbsp;&nbsp;内蒙古奇特投资（集团）有限公司<br><br>424 &nbsp;&nbsp;&nbsp;四川川大华西药业股份有限公司<br><br>425 &nbsp;&nbsp;&nbsp;南京海辰药业有限公司<br><br>426 &nbsp;&nbsp;&nbsp;云南金九地生物科技有限公司<br><br>427 &nbsp;&nbsp;&nbsp;浙江思贤制药有限公司<br><br>428 &nbsp;&nbsp;&nbsp;上海万仕诚国药制品有限公司<br><br>429 &nbsp;&nbsp;&nbsp;上海宝龙药业有限公司<br><br>430 &nbsp;&nbsp;&nbsp;上海卡乐康包衣技术有限公司<br><br>431 &nbsp;&nbsp;&nbsp;桂林天和药业股份有限公司<br><br>432 &nbsp;&nbsp;&nbsp;上海新亚药业有限公司<br><br>433 &nbsp;&nbsp;&nbsp;成都恒瑞制药有限公司<br><br>434 &nbsp;&nbsp;&nbsp;澳诺（中国）制药有限公司<br><br>435 &nbsp;&nbsp;&nbsp;贵州圣济堂制药有限公司<br><br>436 &nbsp;&nbsp;&nbsp;安徽宏业药业有限公司<br><br>437 &nbsp;&nbsp;&nbsp;凯莱英医药化学（阜新）技术有限公司<br><br>438 &nbsp;&nbsp;&nbsp;浙江震元制药有限公司<br><br>439 &nbsp;&nbsp;&nbsp;武汉启瑞药业有限公司<br><br>440 &nbsp;&nbsp;&nbsp;安徽省皖北药业股份有限公司<br><br>441 &nbsp;&nbsp;&nbsp;通化昌源医药科技有限公司<br><br>442 &nbsp;&nbsp;&nbsp;福建南方制药股份有限公司<br><br>443 &nbsp;&nbsp;&nbsp;通化玉圣药业股份有限公司<br><br>444 &nbsp;&nbsp;&nbsp;福建归真堂药业股份有限公司<br><br>445 &nbsp;&nbsp;&nbsp;湖南湘泉药业股份有限公司<br><br>446 &nbsp;&nbsp;&nbsp;北京双鹤高科天然药物有限责任公司<br><br>447 &nbsp;&nbsp;&nbsp;浙江众益药业有限公司<br><br>448 &nbsp;&nbsp;&nbsp;浙江迪耳药业有限公司<br><br>449 &nbsp;&nbsp;&nbsp;宁波市天衡制药有限公司<br><br>450 &nbsp;&nbsp;&nbsp;湖州金洁实业有限公司<br><br>451 &nbsp;&nbsp;&nbsp;麒麟鲲鹏（中国）生物药业有限公司<br><br>452 &nbsp;&nbsp;&nbsp;同溢堂药业有限公司<br><br>453 &nbsp;&nbsp;&nbsp;安丘市鲁安药业有限责任公司<br><br>454 &nbsp;&nbsp;&nbsp;石家庄亿生堂医用品有限公司<br><br>455 &nbsp;&nbsp;&nbsp;华润万东医疗装备股份有限公司<br><br>456 &nbsp;&nbsp;&nbsp;康普药业股份有限公司<br><br>457 &nbsp;&nbsp;&nbsp;通化华夏药业有限责任公司<br><br>458 &nbsp;&nbsp;&nbsp;青州尧王制药有限公司<br><br>459 &nbsp;&nbsp;&nbsp;海南康芝药业股份有限公司<br><br>460 &nbsp;&nbsp;&nbsp;上海虹桥中药饮片有限公司<br><br>461 &nbsp;&nbsp;&nbsp;上海津村制药有限公司<br><br>462 &nbsp;&nbsp;&nbsp;艾博生物医药(杭州)有限公司<br><br>463 &nbsp;&nbsp;&nbsp;兰州佛慈制药股份有限公司<br><br>464 &nbsp;&nbsp;&nbsp;湖北成田制药股份有限公司<br><br>465 &nbsp;&nbsp;&nbsp;云南山灞图像传输科技有限公司<br><br>466 &nbsp;&nbsp;&nbsp;北京谊安医疗系统股份有限公司<br><br>467 &nbsp;&nbsp;&nbsp;海南碧凯药业有限公司<br><br>468 &nbsp;&nbsp;&nbsp;云南天宏香精香料有限公司<br><br>469 &nbsp;&nbsp;&nbsp;云南维和药业股份有限公司<br><br>470 &nbsp;&nbsp;&nbsp;河南省新谊药业股份有限公司<br><br>471 &nbsp;&nbsp;&nbsp;云南白药集团无锡药业有限公司<br><br>472 &nbsp;&nbsp;&nbsp;浙江寿仙谷生物科技有限公司<br><br>473 &nbsp;&nbsp;&nbsp;吉林华康药业股份有限公司<br><br>474 &nbsp;&nbsp;&nbsp;海南通用同盟药业有限公司<br><br>475 &nbsp;&nbsp;&nbsp;内蒙古蒙药股份有限公司<br><br>476 &nbsp;&nbsp;&nbsp;桂林优利特电子集团有限公司<br><br>477 &nbsp;&nbsp;&nbsp;海南澳美华制药有限公司<br><br>478 &nbsp;&nbsp;&nbsp;上海浦东金环医疗用品有限公司<br><br>479 &nbsp;&nbsp;&nbsp;湖南三九南开制药有限公司<br><br>480 &nbsp;&nbsp;&nbsp;云南云河药业股份有限公司<br><br>481 &nbsp;&nbsp;&nbsp;云南特安呐制药股份有限公司<br><br>482 &nbsp;&nbsp;&nbsp;浙江海翔药业股份有限公司<br><br>483 &nbsp;&nbsp;&nbsp;天津中安药业有限公司<br><br>484 &nbsp;&nbsp;&nbsp;西藏自治区藏药厂<br><br>485 &nbsp;&nbsp;&nbsp;甘肃陇神戎发制药有限公司<br><br>486 &nbsp;&nbsp;&nbsp;浙江史密斯医学仪器有限公司<br><br>487 &nbsp;&nbsp;&nbsp;福建天泉药业股份有限公司<br><br>488 &nbsp;&nbsp;&nbsp;湖南春光九汇现代中药有限公司<br><br>489 &nbsp;&nbsp;&nbsp;厦门中药厂有限公司<br><br>490 &nbsp;&nbsp;&nbsp;瓦里安医疗设备（北京）有限公司<br><br>491 &nbsp;&nbsp;&nbsp;德州德药制药有限公司<br><br>492 &nbsp;&nbsp;&nbsp;陕西汉江药业集团股份有限公司<br><br>493 &nbsp;&nbsp;&nbsp;大连库利艾特医疗制品有限公司<br><br>494 &nbsp;&nbsp;&nbsp;南京先声东元制药有限公司<br><br>495 &nbsp;&nbsp;&nbsp;上海雅培制药有限公司<br><br>496 &nbsp;&nbsp;&nbsp;吉林林村中药开发有限公司<br><br>497 &nbsp;&nbsp;&nbsp;宁夏多维药业有限公司<br><br>498 &nbsp;&nbsp;&nbsp;汕头金石制药总厂<br><br>499 &nbsp;&nbsp;&nbsp;甘肃岷海制药有限责任公司<br><br>500 &nbsp;&nbsp;&nbsp;陇西中天药业有限责任公司","source":"雪球"},{"id":23355526,"user_id":6785033954,"title":"2012年中国医药企业500强(按资产总额)完全榜单","created_at":1363959979000,"retweet_count":10,"reply_count":3,"fav_count":24,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"2012年中国医药企业500强完全榜单 （按资产总额） 排名 企业名称 1 中国医药集团总公司 2 广州医药集团有限公司 3 华北制药集团有限责任公司 4 石药集团有限公司 5 天津天士力集团有限公司 6 哈药集团有限公司 7 威高集团有限公司 8 四川科伦药业股份有限公司 9 扬子江药业集团有限公司 10 齐鲁制...","type":"3","source_link":null,"edited_at":1363962210000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23355526","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":35699,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-22 21:46","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"2012年中国医药企业500强完全榜单<br><br>（按资产总额）<br><br>排名 &nbsp;企业名称<br><br>1 &nbsp;中国医药集团总公司<br><br>2 &nbsp;广州医药集团有限公司<br><br>3 &nbsp;华北制药集团有限责任公司<br><br>4 &nbsp;石药集团有限公司<br><br>5 &nbsp;天津天士力集团有限公司<br><br>6 &nbsp;哈药集团有限公司<br><br>7 &nbsp;威高集团有限公司<br><br>8 &nbsp;四川科伦药业股份有限公司<br><br>9 &nbsp;扬子江药业集团有限公司<br><br>10 齐鲁制药有限公司<br><br>11 辅仁药业集团有限公司<br><br>12 修正药业集团股份有限公司<br><br>13 吉林敖东药业集团股份有限公司<br><br>14 浙江海正药业股份有限公司<br><br>15 太极集团有限公司<br><br>16 武汉人福医药集团股份有限公司<br><br>17 杭州华东医药集团有限公司<br><br>18 新和成控股集团有限公司<br><br>19 鲁南制药集团股份有限公司<br><br>20 深圳市海普瑞药业股份有限公司<br><br>21 天津金耀集团有限公司<br><br>22 联邦制药（内蒙古）有限公司<br><br>23 东北制药集团股份有限公司<br><br>24 北京四环制药有限公司<br><br>25 中国远大集团有限责任公司<br><br>26 康恩贝集团有限公司<br><br>27 浙江医药股份有限公司<br><br>28 华润双鹤药业股份有限公司<br><br>29 珠海联邦制药股份有限公司<br><br>30 上海罗氏制药有限公司<br><br>31 江苏恒瑞医药股份有限公司<br><br>32 拜耳医药保健有限公司<br><br>33 丽珠医药集团股份有限公司<br><br>34 健康元药业集团股份有限公司<br><br>35 山东步长制药股份有限公司<br><br>36 山东东阿阿胶股份有限公司<br><br>37 山东绿叶制药集团有限公司<br><br>38 诺和诺德(中国)制药有限公司<br><br>39 天津中新药业集团股份有限公司<br><br>40 中国通用技术（集团）控股有限责任公司<br><br>41 瑞阳制药有限公司<br><br>42 华方医药科技有限公司<br><br>43 河南省宛西制药股份有限公司<br><br>44 江苏康缘集团有限责任公司<br><br>45 神威药业集团有限公司<br><br>46 成都地奥制药集团有限公司<br><br>47 辉瑞制药有限公司<br><br>48 阿斯利康制药有限公司<br><br>49 江苏豪森医药集团有限公司<br><br>50 赛诺菲(杭州)制药有限公司<br><br>51 石家庄以岭药业股份有限公司<br><br>52 百特（中国）投资有限公司<br><br>53 普洛股份有限公司<br><br>54 山东方明药业集团股份有限公司<br><br>55 南京医药产业（集团）有限责任公司<br><br>56 江苏亚邦药业集团股份有限公司<br><br>57 山东鲁抗医药股份有限公司<br><br>58 海南海药股份有限公司<br><br>59 山东新华医药集团有限责任公司<br><br>60 宜昌东阳光药业股份有限公司<br><br>61 仁和（集团）发展有限公司<br><br>62 江西济民可信集团有限公司<br><br>63 三普药业股份有限公司<br><br>64 北京同仁堂健康药业股份有限公司<br><br>65 大冢（中国）投资有限公司<br><br>66 费森尤斯卡比（中国）投资有限公司<br><br>67 浙江华海药业股份有限公司<br><br>68 北大国际医院集团西南合成制药股份有限公司<br><br>69 北京诺华制药有限公司<br><br>70 重庆华邦制药有限公司<br><br>71 天津力生制药股份有限公司<br><br>72 深圳信立泰药业股份有限公司<br><br>73 西安利君制药有限责任公司<br><br>74 亚宝药业集团股份有限公司<br><br>75 江中药业股份有限公司<br><br>76 广州市香雪制药股份有限公司<br><br>77 江苏江山制药有限公司<br><br>78 贵州百灵企业集团制药股份有限公司<br><br>79 浙江尖峰集团股份有限公司<br><br>80 北京同仁堂科技发展股份有限公司<br><br>81 浙江仙琚制药股份有限公司<br><br>82 乐普(北京）医疗器械股份有限公司<br><br>83 杭州民生医药控股集团有限公司<br><br>84 吉林紫鑫药业股份有限公司<br><br>85 山东淄博山川医用器材有限公司<br><br>86 山西振东制药股份有限公司<br><br>87 山东省药用玻璃股份有限公司<br><br>88 哈尔滨誉衡药业股份有限公司<br><br>89 桂林三金药业股份有限公司<br><br>90 青州尧王制药有限公司<br><br>91 江苏正大天晴药业股份有限公司<br><br>92 贵州益佰制药股份有限公司<br><br>93 宁夏泰瑞制药股份有限公司<br><br>94 山东罗欣药业股份有限公司<br><br>95 浙江升华拜克生物股份有限公司<br><br>96 礼来苏州制药有限公司<br><br>97 深圳市海王生物工程股份有限公司<br><br>98 重庆科瑞制药（集团）有限公司<br><br>99 辰欣药业股份有限公司<br><br>100 &nbsp;&nbsp;&nbsp;寿光富康制药有限公司<br><br>101 &nbsp;&nbsp;&nbsp;广西梧州制药(集团)股份有限公司<br><br>102 &nbsp;&nbsp;&nbsp;上海中西三维药业有限公司<br><br>103 &nbsp;&nbsp;&nbsp;葵花药业集团股份有限公司<br><br>104 &nbsp;&nbsp;&nbsp;宁夏启元药业有限公司<br><br>105 &nbsp;&nbsp;&nbsp;双鸽集团有限公司<br><br>106 &nbsp;&nbsp;&nbsp;悦康药业集团有限公司<br><br>107 &nbsp;&nbsp;&nbsp;回音必集团有限公司<br><br>108 &nbsp;&nbsp;&nbsp;西安杨森制药有限公司<br><br>109 &nbsp;&nbsp;&nbsp;成都康弘药业集团<br><br>110 &nbsp;&nbsp;&nbsp;广东太安堂药业股份有限公司<br><br>111 &nbsp;&nbsp;&nbsp;漳州片仔癀药业股份有限公司<br><br>112 &nbsp;&nbsp;&nbsp;山东天力药业有限公司<br><br>113 &nbsp;&nbsp;&nbsp;北京紫竹药业有限公司<br><br>114 &nbsp;&nbsp;&nbsp;常州千红生化制药有限公司<br><br>115 &nbsp;&nbsp;&nbsp;北京双鹭药业股份有限公司<br><br>116 &nbsp;&nbsp;&nbsp;上海中信国健药业有限公司<br><br>117 &nbsp;&nbsp;&nbsp;重庆福安药业（集团）股份有限公司<br><br>118 &nbsp;&nbsp;&nbsp;九芝堂股份有限公司<br><br>119 &nbsp;&nbsp;&nbsp;天津红日药业股份有限公司<br><br>120 &nbsp;&nbsp;&nbsp;微创医疗器械（上海）有限公司<br><br>121 &nbsp;&nbsp;&nbsp;福建省福抗药业股份有限公司<br><br>122 &nbsp;&nbsp;&nbsp;浙江京新药业股份有限公司<br><br>123 &nbsp;&nbsp;&nbsp;上海信谊药厂有限公司<br><br>124 &nbsp;&nbsp;&nbsp;海南康芝药业股份有限公司<br><br>125 &nbsp;&nbsp;&nbsp;辽宁成大生物股份有限公司<br><br>126 &nbsp;&nbsp;&nbsp;上海勃林格殷格翰药业有限公司<br><br>127 &nbsp;&nbsp;&nbsp;广东众生药业股份有限公司<br><br>128 &nbsp;&nbsp;&nbsp;天圣制药集团股份有限公司<br><br>129 &nbsp;&nbsp;&nbsp;山东齐都药业有限公司<br><br>130 &nbsp;&nbsp;&nbsp;中美天津史克制药有限公司<br><br>131 &nbsp;&nbsp;&nbsp;美罗药业股份有限公司<br><br>132 &nbsp;&nbsp;&nbsp;西安力邦制药有限公司<br><br>133 &nbsp;&nbsp;&nbsp;上海迪赛诺化学制药有限公司<br><br>134 &nbsp;&nbsp;&nbsp;山东睿鹰先锋制药有限公司<br><br>135 &nbsp;&nbsp;&nbsp;卫材（中国）药业有限公司<br><br>136 &nbsp;&nbsp;&nbsp;株洲千金药业股份有限公司<br><br>137 &nbsp;&nbsp;&nbsp;北京泰德制药股份有限公司<br><br>138 &nbsp;&nbsp;&nbsp;集安益盛药业股份有限公司<br><br>139 &nbsp;&nbsp;&nbsp;江苏济川制药有限公司<br><br>140 &nbsp;&nbsp;&nbsp;浙江中贝九洲集团有限公司<br><br>141 &nbsp;&nbsp;&nbsp;江苏吴中医药集团有限公司<br><br>142 &nbsp;&nbsp;&nbsp;河南福森药业有限公司<br><br>143 &nbsp;&nbsp;&nbsp;上海凯宝药业股份有限公司<br><br>144 &nbsp;&nbsp;&nbsp;中美上海施贵宝制药有限公司<br><br>145 &nbsp;&nbsp;&nbsp;河南新乡华星药厂<br><br>146 &nbsp;&nbsp;&nbsp;惠氏制药有限公司<br><br>147 &nbsp;&nbsp;&nbsp;诺维信（中国）生物技术有限公司<br><br>148 &nbsp;&nbsp;&nbsp;苏州东瑞制药有限公司<br><br>149 &nbsp;&nbsp;&nbsp;华仁药业股份有限公司<br><br>150 &nbsp;&nbsp;&nbsp;曼秀雷敦（中国）药业有限公司<br><br>151 &nbsp;&nbsp;&nbsp;安徽丰原药业股份有限公司<br><br>152 &nbsp;&nbsp;&nbsp;山东福田药业有限公司<br><br>153 &nbsp;&nbsp;&nbsp;江苏万邦生化医药股份有限公司<br><br>154 &nbsp;&nbsp;&nbsp;上海雷允上药业有限公司<br><br>155 &nbsp;&nbsp;&nbsp;云南特安呐制药股份有限公司<br><br>156 &nbsp;&nbsp;&nbsp;帝斯曼维生素（上海）有限公司<br><br>157 &nbsp;&nbsp;&nbsp;苏州天马医药集团有限公司<br><br>158 &nbsp;&nbsp;&nbsp;浙江海翔药业股份有限公司<br><br>159 &nbsp;&nbsp;&nbsp;横店集团家园化工有限公司<br><br>160 &nbsp;&nbsp;&nbsp;联邦制药（成都）有限公司<br><br>161 &nbsp;&nbsp;&nbsp;山德士(中国)制药有限公司<br><br>162 &nbsp;&nbsp;&nbsp;上海康德莱企业发展集团股份有限公司<br><br>163 &nbsp;&nbsp;&nbsp;江苏恩华药业股份有限公司<br><br>164 &nbsp;&nbsp;&nbsp;上海新亚药业有限公司<br><br>165 &nbsp;&nbsp;&nbsp;江苏联环药业集团有限公司<br><br>166 &nbsp;&nbsp;&nbsp;秦皇岛骊骅淀粉股份有限公司<br><br>167 &nbsp;&nbsp;&nbsp;正大青春宝药业有限公司<br><br>168 &nbsp;&nbsp;&nbsp;沈阳三生制药有限责任公司<br><br>169 &nbsp;&nbsp;&nbsp;河南新帅克制药股份有限公司<br><br>170 &nbsp;&nbsp;&nbsp;四川省宜宾五粮液集团宜宾制药有限责任公司<br><br>171 &nbsp;&nbsp;&nbsp;安丘市鲁安药业有限责任公司<br><br>172 &nbsp;&nbsp;&nbsp;辽宁诺康生物制药有限责任公司<br><br>173 &nbsp;&nbsp;&nbsp;南京先声东元制药有限公司<br><br>174 &nbsp;&nbsp;&nbsp;山东鲁维制药有限公司<br><br>175 &nbsp;&nbsp;&nbsp;中国医学科学院医学生物学研究所<br><br>176 &nbsp;&nbsp;&nbsp;黑龙江江世药业有限公司<br><br>177 &nbsp;&nbsp;&nbsp;常州四药制药有限公司<br><br>178 &nbsp;&nbsp;&nbsp;上海莱士血液制品股份有限公司<br><br>179 &nbsp;&nbsp;&nbsp;重庆药友制药有限责任公司<br><br>180 &nbsp;&nbsp;&nbsp;通用电气药业（上海）有限公司<br><br>181 &nbsp;&nbsp;&nbsp;江西汇仁药业有限公司<br><br>182 &nbsp;&nbsp;&nbsp;金花企业（集团）股份有限公司<br><br>183 &nbsp;&nbsp;&nbsp;深圳翰宇药业股份有限公司<br><br>184 &nbsp;&nbsp;&nbsp;浙江国邦药业有限公司<br><br>185 &nbsp;&nbsp;&nbsp;青岛黄海制药有限责任公司<br><br>186 &nbsp;&nbsp;&nbsp;长春长生生物科技股份有限公司<br><br>187 &nbsp;&nbsp;&nbsp;迪沙药业集团有限公司<br><br>188 &nbsp;&nbsp;&nbsp;华润万东医疗装备股份有限公司<br><br>189 &nbsp;&nbsp;&nbsp;福建三爱药业有限公司<br><br>190 &nbsp;&nbsp;&nbsp;四川好医生药业集团有限公司<br><br>191 &nbsp;&nbsp;&nbsp;江苏苏中药业集团股份有限公司<br><br>192 &nbsp;&nbsp;&nbsp;湖南汉森制药股份有限公司<br><br>193 &nbsp;&nbsp;&nbsp;海南惠普森医药生物技术有限公司<br><br>194 &nbsp;&nbsp;&nbsp;贵州同济堂制药有限公司<br><br>195 &nbsp;&nbsp;&nbsp;通化万通药业股份有限公司<br><br>196 &nbsp;&nbsp;&nbsp;四川百利药业有限责任公司<br><br>197 &nbsp;&nbsp;&nbsp;西安万隆制药股份有限公司<br><br>198 &nbsp;&nbsp;&nbsp;湖北新生源生物工程股份有限公司<br><br>199 &nbsp;&nbsp;&nbsp;绍兴振德医用敷料有限公司<br><br>200 &nbsp;&nbsp;&nbsp;沈阳抗生素厂<br><br>201 &nbsp;&nbsp;&nbsp;康美新开河（吉林）药业有限公司<br><br>202 &nbsp;&nbsp;&nbsp;北京华素制药股份有限公司<br><br>203 &nbsp;&nbsp;&nbsp;四川恩威制药有限公司<br><br>204 &nbsp;&nbsp;&nbsp;赛诺菲（北京）制药有限公司<br><br>205 &nbsp;&nbsp;&nbsp;江西青峰药业有限公司<br><br>206 &nbsp;&nbsp;&nbsp;鲁南厚普制药有限公司<br><br>207 &nbsp;&nbsp;&nbsp;通化久铭药业有限公司<br><br>208 &nbsp;&nbsp;&nbsp;昆山龙灯瑞迪制药有限公司<br><br>209 &nbsp;&nbsp;&nbsp;精华制药集团股份有限公司<br><br>210 &nbsp;&nbsp;&nbsp;北京绿竹生物制药有限公司<br><br>211 &nbsp;&nbsp;&nbsp;湖南千山制药机械股份有限公司<br><br>212 &nbsp;&nbsp;&nbsp;北京同仁堂健康药业(福州)有限公司<br><br>213 &nbsp;&nbsp;&nbsp;滇虹药业集团股份有限公司<br><br>214 &nbsp;&nbsp;&nbsp;吉林金宝药业股份有限公司<br><br>215 &nbsp;&nbsp;&nbsp;牡丹江友搏药业股份有限公司<br><br>216 &nbsp;&nbsp;&nbsp;昆明积大制药股份有限公司<br><br>217 &nbsp;&nbsp;&nbsp;桂林南药股份有限公司<br><br>218 &nbsp;&nbsp;&nbsp;安斯泰来制药（中国）有限公司<br><br>219 &nbsp;&nbsp;&nbsp;北京科兴生物制品有限公司<br><br>220 &nbsp;&nbsp;&nbsp;上海第一生化药业有限公司<br><br>221 &nbsp;&nbsp;&nbsp;潍坊盛泰药业有限公司<br><br>222 &nbsp;&nbsp;&nbsp;浙江天宇药业股份有限公司<br><br>223 &nbsp;&nbsp;&nbsp;山东福胶集团有限公司<br><br>224 &nbsp;&nbsp;&nbsp;海南双成药业股份有限公司<br><br>225 &nbsp;&nbsp;&nbsp;上海强生制药有限公司<br><br>226 &nbsp;&nbsp;&nbsp;泰尔茂医疗产品(杭州)有限公司<br><br>227 &nbsp;&nbsp;&nbsp;浙江佐力药业股份有限公司<br><br>228 &nbsp;&nbsp;&nbsp;广东一方制药有限公司<br><br>229 &nbsp;&nbsp;&nbsp;内蒙古福瑞医疗科技股份有限公司<br><br>230 &nbsp;&nbsp;&nbsp;通化金马药业集团股份有限公司<br><br>231 &nbsp;&nbsp;&nbsp;青岛国风药业股份有限公司<br><br>232 &nbsp;&nbsp;&nbsp;山东润泽制药有限公司<br><br>233 &nbsp;&nbsp;&nbsp;江苏奥赛康药业股份有限公司<br><br>234 &nbsp;&nbsp;&nbsp;山东宏济堂制药集团有限公司<br><br>235 &nbsp;&nbsp;&nbsp;海南亚洲制药有限公司<br><br>236 &nbsp;&nbsp;&nbsp;浙江司太立制药股份有限公司<br><br>237 &nbsp;&nbsp;&nbsp;广东环球制药有限公司<br><br>238 &nbsp;&nbsp;&nbsp;浙江亚太药业股份有限公司<br><br>239 &nbsp;&nbsp;&nbsp;浙江海翔川南药业有限公司<br><br>240 &nbsp;&nbsp;&nbsp;泰普生物科学（中国）有限公司<br><br>241 &nbsp;&nbsp;&nbsp;雅安三九药业有限公司<br><br>242 &nbsp;&nbsp;&nbsp;浙江海力生制药有限公司<br><br>243 &nbsp;&nbsp;&nbsp;兰州佛慈制药股份有限公司<br><br>244 &nbsp;&nbsp;&nbsp;海南卫康制药（潜山）有限公司<br><br>245 &nbsp;&nbsp;&nbsp;江西洪达医疗器械集团有限公司<br><br>246 &nbsp;&nbsp;&nbsp;承德颈复康药业集团有限公司<br><br>247 &nbsp;&nbsp;&nbsp;云南植物药业有限公司<br><br>248 &nbsp;&nbsp;&nbsp;山西康宝生物制品股份有限公司<br><br>249 &nbsp;&nbsp;&nbsp;重庆希尔安药业有限公司<br><br>250 &nbsp;&nbsp;&nbsp;江西博雅生物制药股份有限公司<br><br>251 &nbsp;&nbsp;&nbsp;楚天科技股份有限公司<br><br>252 &nbsp;&nbsp;&nbsp;唐山容大药业有限公司<br><br>253 &nbsp;&nbsp;&nbsp;浙江天皇药业有限公司<br><br>254 &nbsp;&nbsp;&nbsp;珍奥集团股份有限公司<br><br>255 &nbsp;&nbsp;&nbsp;北京赛科药业有限责任公司<br><br>256 &nbsp;&nbsp;&nbsp;金宇保灵生物药品有限公司<br><br>257 &nbsp;&nbsp;&nbsp;四川方向药业有限责任公司<br><br>258 &nbsp;&nbsp;&nbsp;宜昌三峡制药有限公司<br><br>259 &nbsp;&nbsp;&nbsp;甘肃扶正药业科技股份有限公司<br><br>260 &nbsp;&nbsp;&nbsp;湖南有色凯铂生物药业有限公司<br><br>261 &nbsp;&nbsp;&nbsp;英科新创（厦门）科技有限公司<br><br>262 &nbsp;&nbsp;&nbsp;山西仟源制药股份有限公司<br><br>263 &nbsp;&nbsp;&nbsp;紫光古汉集团股份有限公司<br><br>264 &nbsp;&nbsp;&nbsp;海南中和药业有限公司<br><br>265 &nbsp;&nbsp;&nbsp;苏州百特医疗用品有限公司<br><br>266 &nbsp;&nbsp;&nbsp;深圳万乐药业有限公司<br><br>267 &nbsp;&nbsp;&nbsp;云南龙润药业有限公司<br><br>268 &nbsp;&nbsp;&nbsp;山东齐发药业有限公司<br><br>269 &nbsp;&nbsp;&nbsp;宜昌奥美医疗用品有限公司<br><br>270 &nbsp;&nbsp;&nbsp;山西普德药业股份有限公司<br><br>271 &nbsp;&nbsp;&nbsp;江西益康医疗器械集团有限公司<br><br>272 &nbsp;&nbsp;&nbsp;哈尔滨仁皇药业有限公司<br><br>273 &nbsp;&nbsp;&nbsp;天津华津制药有限公司<br><br>274 &nbsp;&nbsp;&nbsp;长春金赛药业股份有限公司<br><br>275 &nbsp;&nbsp;&nbsp;浙江新东港药业股份有限公司<br><br>276 &nbsp;&nbsp;&nbsp;深圳市卫武光明生物制品有限公司<br><br>277 &nbsp;&nbsp;&nbsp;施慧达药业集团（吉林）有限公司<br><br>278 &nbsp;&nbsp;&nbsp;四川禾邦阳光制药股份有限公司<br><br>279 &nbsp;&nbsp;&nbsp;海口奇力制药股份有限公司<br><br>280 &nbsp;&nbsp;&nbsp;宁波戴维医疗器械有限公司<br><br>281 &nbsp;&nbsp;&nbsp;湖州数康生物科技有限公司<br><br>282 &nbsp;&nbsp;&nbsp;浙江震元制药有限公司<br><br>283 &nbsp;&nbsp;&nbsp;海南海灵化学制药有限公司<br><br>284 &nbsp;&nbsp;&nbsp;山东沃华医药科技股份有限公司<br><br>285 &nbsp;&nbsp;&nbsp;甘李药业有限公司<br><br>286 &nbsp;&nbsp;&nbsp;北京嘉林药业股份有限公司<br><br>287 &nbsp;&nbsp;&nbsp;四川逢春制药有限公司<br><br>288 &nbsp;&nbsp;&nbsp;山东达因海洋生物制药股份有限公司<br><br>289 &nbsp;&nbsp;&nbsp;贵州百花医药股份有限公司<br><br>290 &nbsp;&nbsp;&nbsp;贵州泰邦生物制品有限公司<br><br>291 &nbsp;&nbsp;&nbsp;江西国药有限责任公司<br><br>292 &nbsp;&nbsp;&nbsp;甘肃独一味生物制药股份有限公司<br><br>293 &nbsp;&nbsp;&nbsp;江西药都医药集团股份有限公司<br><br>294 &nbsp;&nbsp;&nbsp;黑龙江福和华星制药集团股份有限公司<br><br>295 &nbsp;&nbsp;&nbsp;浙江贝得药业有限公司<br><br>296 &nbsp;&nbsp;&nbsp;吉林省都邦药业股份有限公司<br><br>297 &nbsp;&nbsp;&nbsp;黑龙江乌苏里江制药有限公司<br><br>298 &nbsp;&nbsp;&nbsp;吉林省通化振国药业有限公司<br><br>299 &nbsp;&nbsp;&nbsp;四川升和药业股份有限公司<br><br>300 &nbsp;&nbsp;&nbsp;第一三共制药（北京）有限公司<br><br>301 &nbsp;&nbsp;&nbsp;上海华宇药业有限公司<br><br>302 &nbsp;&nbsp;&nbsp;赤峰制药股份有限公司<br><br>303 &nbsp;&nbsp;&nbsp;辽宁依生生物制药有限公司<br><br>304 &nbsp;&nbsp;&nbsp;珠海安生医药有限公司<br><br>305 &nbsp;&nbsp;&nbsp;湖北省宏源药业有限公司<br><br>306 &nbsp;&nbsp;&nbsp;四川志远广和制药有限公司<br><br>307 &nbsp;&nbsp;&nbsp;浙江永宁制药厂<br><br>308 &nbsp;&nbsp;&nbsp;上海希迪制药有限公司<br><br>309 &nbsp;&nbsp;&nbsp;上海和黄药业有限公司<br><br>310 &nbsp;&nbsp;&nbsp;江西普正制药有限公司<br><br>311 &nbsp;&nbsp;&nbsp;北京北陆药业股份有限公司<br><br>312 &nbsp;&nbsp;&nbsp;黑龙江北大荒药业有限公司<br><br>313 &nbsp;&nbsp;&nbsp;吉林省辉南长龙生化药业股份有限公司<br><br>314 &nbsp;&nbsp;&nbsp;浙江华康药业股份有限公司<br><br>315 &nbsp;&nbsp;&nbsp;北京韩美药品有限公司<br><br>316 &nbsp;&nbsp;&nbsp;上海中西制药有限公司<br><br>317 &nbsp;&nbsp;&nbsp;上海景峰制药股份有限公司<br><br>318 &nbsp;&nbsp;&nbsp;通化茂祥制药有限公司<br><br>319 &nbsp;&nbsp;&nbsp;北京康仁堂药业有限公司<br><br>320 &nbsp;&nbsp;&nbsp;西安大唐制药集团有限公司<br><br>321 &nbsp;&nbsp;&nbsp;湘北威尔曼制药股份有限公司<br><br>322 &nbsp;&nbsp;&nbsp;施维雅（天津）制药有限公司<br><br>323 &nbsp;&nbsp;&nbsp;云南盘龙云海药业有限公司<br><br>324 &nbsp;&nbsp;&nbsp;百泰生物药业有限公司<br><br>325 &nbsp;&nbsp;&nbsp;哈尔滨三联药业有限公司<br><br>326 &nbsp;&nbsp;&nbsp;华夏药业集团有限公司<br><br>327 &nbsp;&nbsp;&nbsp;吉林华康药业股份有限公司<br><br>328 &nbsp;&nbsp;&nbsp;东软飞利浦医疗设备系统有限责任公司<br><br>329 &nbsp;&nbsp;&nbsp;陕西必康制药有限公司<br><br>330 &nbsp;&nbsp;&nbsp;上海津村制药有限公司<br><br>331 &nbsp;&nbsp;&nbsp;宁波人健药业集团股份有限公司<br><br>332 &nbsp;&nbsp;&nbsp;云南东融中药饮片厂<br><br>333 &nbsp;&nbsp;&nbsp;聊城万合工业制造有限公司<br><br>334 &nbsp;&nbsp;&nbsp;锦州奥鸿药业有限责任公司<br><br>335 &nbsp;&nbsp;&nbsp;贵州健兴药业有限公司<br><br>336 &nbsp;&nbsp;&nbsp;贵阳德昌祥药业有限公司<br><br>337 &nbsp;&nbsp;&nbsp;陕西汉江药业集团股份有限公司<br><br>338 &nbsp;&nbsp;&nbsp;浙江昂利康制药有限公司<br><br>339 &nbsp;&nbsp;&nbsp;艾博生物医药(杭州)有限公司<br><br>340 &nbsp;&nbsp;&nbsp;四川奥邦药业有限公司<br><br>341 &nbsp;&nbsp;&nbsp;北京协和制药二厂<br><br>342 &nbsp;&nbsp;&nbsp;北京利祥制药有限公司<br><br>343 &nbsp;&nbsp;&nbsp;哈尔滨蒲公英药业有限公司<br><br>344 &nbsp;&nbsp;&nbsp;东盛科技启东盖天力制药股份有限公司<br><br>345 &nbsp;&nbsp;&nbsp;四川省百草生物药业有限公司<br><br>346 &nbsp;&nbsp;&nbsp;杭州赛诺菲民生健康药业有限公司<br><br>347 &nbsp;&nbsp;&nbsp;浙江天元生物药业有限公司<br><br>348 &nbsp;&nbsp;&nbsp;浙江莎普爱思药业股份有限公司<br><br>349 &nbsp;&nbsp;&nbsp;烟台荣昌制药股份有限公司<br><br>350 &nbsp;&nbsp;&nbsp;诸城市浩天药业有限公司<br><br>351 &nbsp;&nbsp;&nbsp;陕西海天制药有限公司<br><br>352 &nbsp;&nbsp;&nbsp;欧姆龙（大连）有限公司<br><br>353 &nbsp;&nbsp;&nbsp;甘肃成纪生物药业有限公司<br><br>354 &nbsp;&nbsp;&nbsp;北京世桥生物制药有限公司<br><br>355 &nbsp;&nbsp;&nbsp;四川康定金珠制药有限责任公司<br><br>356 &nbsp;&nbsp;&nbsp;云南维和药业股份有限公司<br><br>357 &nbsp;&nbsp;&nbsp;河南省新谊药业股份有限公司<br><br>358 &nbsp;&nbsp;&nbsp;上海华源安徽仁济制药有限公司<br><br>359 &nbsp;&nbsp;&nbsp;云南生物谷药业股份有限公司<br><br>360 &nbsp;&nbsp;&nbsp;广西金嗓子有限责任公司<br><br>361 &nbsp;&nbsp;&nbsp;四川美大康药业股份有限公司<br><br>362 &nbsp;&nbsp;&nbsp;黑龙江天宏药业有限公司<br><br>363 &nbsp;&nbsp;&nbsp;国药集团容生制药有限公司<br><br>364 &nbsp;&nbsp;&nbsp;广东太阳神集团有限公司<br><br>365 &nbsp;&nbsp;&nbsp;四川海思科制药有限公司<br><br>366 &nbsp;&nbsp;&nbsp;上海先灵葆雅制药有限公司<br><br>367 &nbsp;&nbsp;&nbsp;汕头市超声仪器研究所有限公司<br><br>368 &nbsp;&nbsp;&nbsp;宁波立华制药有限公司<br><br>369 &nbsp;&nbsp;&nbsp;四川新荷花中药饮片股份有限公司<br><br>370 &nbsp;&nbsp;&nbsp;哈尔滨圣泰制药股份有限公司<br><br>371 &nbsp;&nbsp;&nbsp;苏州中化药品工业有限公司<br><br>372 &nbsp;&nbsp;&nbsp;江西百神药业股份有限公司<br><br>373 &nbsp;&nbsp;&nbsp;北京博士伦眼睛护理产品有限公司<br><br>374 &nbsp;&nbsp;&nbsp;四川源基制药有限公司<br><br>375 &nbsp;&nbsp;&nbsp;蓬莱诺康药业有限公司<br><br>376 &nbsp;&nbsp;&nbsp;松下电气机器（北京）有限公司<br><br>377 &nbsp;&nbsp;&nbsp;四川禾润制药有公司<br><br>378 &nbsp;&nbsp;&nbsp;江西东风药业股份有限公司<br><br>379 &nbsp;&nbsp;&nbsp;山西广生医药包装股份有限公司<br><br>380 &nbsp;&nbsp;&nbsp;浙江亚克药业有限公司<br><br>381 &nbsp;&nbsp;&nbsp;麒麟鲲鹏（中国）生物药业有限公司<br><br>382 &nbsp;&nbsp;&nbsp;山东侨牌集团有限公司<br><br>383 &nbsp;&nbsp;&nbsp;山东博士伦福瑞达制药有限公司<br><br>384 &nbsp;&nbsp;&nbsp;浙江康乐药业股份有限公司<br><br>385 &nbsp;&nbsp;&nbsp;云南山灞图像传输科技有限公司<br><br>386 &nbsp;&nbsp;&nbsp;内蒙古亿利科技实业股份有限公司甘草分公司<br><br>387 &nbsp;&nbsp;&nbsp;昆明圣火药业（集团）有限公司<br><br>388 &nbsp;&nbsp;&nbsp;浙江大德药业集团有限公司<br><br>389 &nbsp;&nbsp;&nbsp;北京协和药厂<br><br>390 &nbsp;&nbsp;&nbsp;成都华神集团股份有限公司<br><br>391 &nbsp;&nbsp;&nbsp;山东华鲁制药有限公司<br><br>392 &nbsp;&nbsp;&nbsp;天津市中津制药股份有限公司<br><br>393 &nbsp;&nbsp;&nbsp;重庆华森制药有限公司<br><br>394 &nbsp;&nbsp;&nbsp;山东凤凰制药股份有限公司<br><br>395 &nbsp;&nbsp;&nbsp;浙江花园药业有限公司<br><br>396 &nbsp;&nbsp;&nbsp;吉林万通药业集团梅河药业股份有限公司<br><br>397 &nbsp;&nbsp;&nbsp;湖南泰尔制药股份有限公司<br><br>398 &nbsp;&nbsp;&nbsp;北京谊安医疗系统股份有限公司<br><br>399 &nbsp;&nbsp;&nbsp;珠海亿邦制药股份有限公司<br><br>400 &nbsp;&nbsp;&nbsp;杭州胡庆余堂药业有限公司<br><br>401 &nbsp;&nbsp;&nbsp;江苏柯菲平医药有限公司<br><br>402 &nbsp;&nbsp;&nbsp;南京圣和药业有限公司<br><br>403 &nbsp;&nbsp;&nbsp;浙江耐司康药业有限公司<br><br>404 &nbsp;&nbsp;&nbsp;苏州二叶制药有限公司<br><br>405 &nbsp;&nbsp;&nbsp;重庆正川玻璃有限公司<br><br>406 &nbsp;&nbsp;&nbsp;宁波市天衡制药有限公司<br><br>407 &nbsp;&nbsp;&nbsp;北京九强生物技术有限公司<br><br>408 &nbsp;&nbsp;&nbsp;四川省长征药业股份有限公司<br><br>409 &nbsp;&nbsp;&nbsp;哈尔滨派斯菲科生物制药股份有限公司<br><br>410 &nbsp;&nbsp;&nbsp;安徽金蟾生化股份有限公司<br><br>411 &nbsp;&nbsp;&nbsp;丹东医创药业有限责任公司<br><br>412 &nbsp;&nbsp;&nbsp;浙江新华制药有限公司<br><br>413 &nbsp;&nbsp;&nbsp;云南天宏香精香料有限公司<br><br>414 &nbsp;&nbsp;&nbsp;吉林省辉南辉发制药股份有限公司<br><br>415 &nbsp;&nbsp;&nbsp;厦门金日制药有限公司<br><br>416 &nbsp;&nbsp;&nbsp;浙江天新药业有限公司<br><br>417 &nbsp;&nbsp;&nbsp;桂林天和药业股份有限公司<br><br>418 &nbsp;&nbsp;&nbsp;云南瑞宝生物科技有限公司<br><br>419 &nbsp;&nbsp;&nbsp;第一三共制药（上海）有限公司<br><br>420 &nbsp;&nbsp;&nbsp;艾康生物技术（杭州）有限公司<br><br>421 &nbsp;&nbsp;&nbsp;安徽省皖北药业股份有限公司<br><br>422 &nbsp;&nbsp;&nbsp;浙江普康生物技术股份有限公司<br><br>423 &nbsp;&nbsp;&nbsp;广东一力集团制药有限公司<br><br>424 &nbsp;&nbsp;&nbsp;湖北省八峰药化股份有限公司<br><br>425 &nbsp;&nbsp;&nbsp;浙江万马药业有限公司<br><br>426 &nbsp;&nbsp;&nbsp;贵州拜特制药有限公司<br><br>427 &nbsp;&nbsp;&nbsp;深圳九新药业有限公司<br><br>428 &nbsp;&nbsp;&nbsp;北京万泰生物药业股份有限公司<br><br>429 &nbsp;&nbsp;&nbsp;浙江康莱特药业有限公司<br><br>430 &nbsp;&nbsp;&nbsp;成都天台山制药有限公司<br><br>431 &nbsp;&nbsp;&nbsp;中化帝斯曼制药（淄博）有限公司<br><br>432 &nbsp;&nbsp;&nbsp;山东祥瑞药业有限公司<br><br>433 &nbsp;&nbsp;&nbsp;秦皇岛紫竹药业有限公司<br><br>434 &nbsp;&nbsp;&nbsp;天津药物研究院药业有限责任公司<br><br>435 &nbsp;&nbsp;&nbsp;云南天创科技有限公司<br><br>436 &nbsp;&nbsp;&nbsp;武汉启瑞药业有限公司<br><br>437 &nbsp;&nbsp;&nbsp;浙江诚意药业有限公司<br><br>438 &nbsp;&nbsp;&nbsp;合肥平光制药有限公司<br><br>439 &nbsp;&nbsp;&nbsp;桂林优利特电子集团有限公司<br><br>440 &nbsp;&nbsp;&nbsp;广东台城制药股份有限公司<br><br>441 &nbsp;&nbsp;&nbsp;天津市天成制药有限公司<br><br>442 &nbsp;&nbsp;&nbsp;西安环球印务股份有限公司<br><br>443 &nbsp;&nbsp;&nbsp;宁波鑫高益磁材有限公司<br><br>444 &nbsp;&nbsp;&nbsp;江西3L医用制品集团股份有限公司<br><br>445 &nbsp;&nbsp;&nbsp;大连汉信生物制药有限公司<br><br>446 &nbsp;&nbsp;&nbsp;浙江寿仙谷生物科技有限公司<br><br>447 &nbsp;&nbsp;&nbsp;贵州益康制药有限公司<br><br>448 &nbsp;&nbsp;&nbsp;重庆圣华曦药业有限公司<br><br>449 &nbsp;&nbsp;&nbsp;昆明龙津药业股份有限公司<br><br>450 &nbsp;&nbsp;&nbsp;北京赛升药业股份有限公司<br><br>451 &nbsp;&nbsp;&nbsp;海南皇隆制药厂有限公司<br><br>452 &nbsp;&nbsp;&nbsp;广东彼迪药业有限公司<br><br>453 &nbsp;&nbsp;&nbsp;康普药业股份有限公司<br><br>454 &nbsp;&nbsp;&nbsp;四川迪康科技药业股份有限公司<br><br>455 &nbsp;&nbsp;&nbsp;四川中方制药有限公司<br><br>456 &nbsp;&nbsp;&nbsp;广东立国制药有限公司<br><br>457 &nbsp;&nbsp;&nbsp;万特制药(海南)有限公司<br><br>458 &nbsp;&nbsp;&nbsp;海南碧凯药业有限公司<br><br>459 &nbsp;&nbsp;&nbsp;贵阳新天药业股份有限公司<br><br>460 &nbsp;&nbsp;&nbsp;北京星昊医药股份有限公司<br><br>461 &nbsp;&nbsp;&nbsp;南京长澳制药有限公司<br><br>462 &nbsp;&nbsp;&nbsp;江苏省健尔康医用敷料有限公司<br><br>463 &nbsp;&nbsp;&nbsp;厦门特宝生物工程股份有限公司<br><br>464 &nbsp;&nbsp;&nbsp;湖北百科亨迪药业有限公司<br><br>465 &nbsp;&nbsp;&nbsp;三菱制药（广州）有限公司<br><br>466 &nbsp;&nbsp;&nbsp;上海美恩生物技术有限公司<br><br>467 &nbsp;&nbsp;&nbsp;浙江康德莱医疗器械股份有限公司<br><br>468 &nbsp;&nbsp;&nbsp;河北九派制药股份有限公司<br><br>469 &nbsp;&nbsp;&nbsp;上海复旦复华药业有限公司<br><br>470 &nbsp;&nbsp;&nbsp;太阳石（唐山）药业有限公司<br><br>471 &nbsp;&nbsp;&nbsp;海南灵康药业集团股份有限公司<br><br>472 &nbsp;&nbsp;&nbsp;施强药业集团有限公司<br><br>473 &nbsp;&nbsp;&nbsp;浙江万联药业有限公司<br><br>474 &nbsp;&nbsp;&nbsp;天津美伦医药集团有限公司<br><br>475 &nbsp;&nbsp;&nbsp;云南良方制药有限公司<br><br>476 &nbsp;&nbsp;&nbsp;雅培眼力健（杭州）制药有限公司<br><br>477 &nbsp;&nbsp;&nbsp;上海宝龙药业有限公司<br><br>478 &nbsp;&nbsp;&nbsp;山东明仁福瑞达制药股份有限公司<br><br>479 &nbsp;&nbsp;&nbsp;宁夏多维药业有限公司<br><br>480 &nbsp;&nbsp;&nbsp;福建归真堂药业股份有限公司<br><br>481 &nbsp;&nbsp;&nbsp;旭化成医疗器械（杭州）有限公司<br><br>482 &nbsp;&nbsp;&nbsp;海南通用同盟药业有限公司<br><br>483 &nbsp;&nbsp;&nbsp;深圳市中核海得威生物科技有限公司<br><br>484 &nbsp;&nbsp;&nbsp;麦克奥迪实业集团有限公司<br><br>485 &nbsp;&nbsp;&nbsp;云南腾药制药股份有限公司<br><br>486 &nbsp;&nbsp;&nbsp;上海昊海生物科技有限公司<br><br>487 &nbsp;&nbsp;&nbsp;贵州光正制药有限责任公司<br><br>488 &nbsp;&nbsp;&nbsp;湖南尔康制药有限公司<br><br>489 &nbsp;&nbsp;&nbsp;宁波绿之健药业有限公司<br><br>490 &nbsp;&nbsp;&nbsp;湖南方盛制药股份有限公司<br><br>491 &nbsp;&nbsp;&nbsp;山东鑫泉医药有限公司<br><br>492 &nbsp;&nbsp;&nbsp;上海迪赛诺生物医药有限公司<br><br>493 &nbsp;&nbsp;&nbsp;海南三叶制药厂有限公司<br><br>494 &nbsp;&nbsp;&nbsp;广东联康药业有限公司<br><br>495 &nbsp;&nbsp;&nbsp;杭州天目山药业股份有限公司<br><br>496 &nbsp;&nbsp;&nbsp;西藏自治区藏药厂<br><br>497 &nbsp;&nbsp;&nbsp;广西玉林制药集团有限责任公司<br><br>498 &nbsp;&nbsp;&nbsp;诚达药业股份有限公司<br><br>499 &nbsp;&nbsp;&nbsp;浙江车头制药有限公司<br><br>500 &nbsp;&nbsp;&nbsp;大理药业股份有限公司","source":"雪球"},{"id":23355280,"user_id":6785033954,"title":"","created_at":1363958517000,"retweet_count":3,"reply_count":3,"fav_count":3,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600028\"   target=\"_blank\">$中国石化(SH600028)$</a> 可能大家想不道的是中国石化会成为股市中的黑马。大家一致骂的中国石化成为了2013涨势最喜人的牛股,这不合人情但符合投资之道。","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23355280","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":342,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-22 21:21","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600028\"   target=\"_blank\">$中国石化(SH600028)$</a> 可能大家想不道的是中国石化会成为股市中的黑马。大家一致骂的中国石化成为了2013涨势最喜人的牛股,这不合人情但符合投资之道。","source":"雪球"},{"id":23345033,"user_id":6785033954,"title":"四川省3年内为成长性环保企业提供不低于100亿元的授信额度","created_at":1363881608000,"retweet_count":1,"reply_count":1,"fav_count":2,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SZ000598\"   target=\"_blank\">$兴蓉投资(SZ000598)$</a> 3年内为成长性环保企业提供不低于100亿元的授信额度 推荐条件： 环保技术工艺应在全国或全川具有领先性优势，具有核心技术产品，且产品具有较大市场需求 企业过去3年内没有环境违法行为 金融服务： 贷款、保险、上市等一揽子业务支持 3月18日举行的环保产业金融服务战略合作...","type":"3","source_link":null,"edited_at":1363881655000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23345033","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":401,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-22 00:00","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SZ000598\"   target=\"_blank\">$兴蓉投资(SZ000598)$</a> 3年内为成长性环保企业提供不低于100亿元的授信额度<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;推荐条件：<br><br>　　环保技术工艺应在全国或全川具有领先性优势，具有核心技术产品，且产品具有较大市场需求<br><br>　　企业过去3年内没有环境违法行为<br><br>　　金融服务：<br><br>　　贷款、保险、上市等一揽子业务支持<br><br>　　3月18日举行的环保产业金融服务战略合作协议签约仪式上，中国银行四川省分行与四川深蓝环保科技股份有限公司和四川海天水务集团有限公司签订了3500万元贷款协议。为促进四川环保产业发展壮大，省环保厅和中国银行将共同搭建环保融资平台，3年内，中国银行四川省分行将为省环保厅推荐的成长性环保企业提供不低于100亿元的授信额度。<br><br>　　省环保厅负责人介绍，银行授信企业将从成长性环保企业中筛选。推荐企业的基本条件除具有运营资质外，企业的环保技术工艺应在全国或全川具有领先性优势，具有核心技术产品，且产品具有较大市场需求。此外，企业在过去3年内没有环境违法行为。目前，省环保厅已初步筛选出20家成长性环保企业，首批推荐给中国银行四川省分行。四川深蓝环保科技股份有限公司和四川海天水务集团有限公司就是其中的两家。<br><br>　　按照合作协议，中国银行四川省分行将对省环保厅及环保产业融资平台推荐的成长性环保企业，在未来3年给予不低于100亿元的授信额度支持，并提供中银保险服务、财务顾问、上市中介推荐、上市后资金管理等一揽子业务支持。<br><br>　　省环保厅和中国银行将联合设立“环保产业金融服务工作站”作为融资平台的常设机构，引导环保企业进入环保融资平台，并向平台内企业优先提供环保政策支持、技术指导、环保补贴等政策。<br><br>　　中国银行四川省分行负责人表示，该行将根据环保企业发展不同阶段的融资需求，利用中国银行集团的中银投资、中银国际、中银证券、中银保险等多元化优势和国际化网络，创造“贷款+投资+上市”及“境外+境内+本地”融资模式，培育和支持环保产业发展。 （记者 刘宇男）","source":"雪球"},{"id":23344249,"user_id":6785033954,"title":"","created_at":1363875829000,"retweet_count":0,"reply_count":2,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> DROMCT 回复 zangyn： 茅台是几百年的品牌了，号称国酒，就算现在被做空，在国人心中长期形成的地位天士力能比？ zangyn 回复 DROMCT： 这是投资！你说的几百年、国酒这些在资本市场里恰恰是弱势，举个最简单的例子，这几年白酒股涨幅中茅台涨幅是最少最少的，前两名回报率是...","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23344249","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":293,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-21 22:23","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> DROMCT 回复 zangyn：<br>茅台是几百年的品牌了，号称国酒，就算现在被做空，在国人心中长期形成的地位天士力能比？<br>zangyn 回复 DROMCT：<br>这是投资！你说的几百年、国酒这些在资本市场里恰恰是弱势，举个最简单的例子，这几年白酒股涨幅中茅台涨幅是最少最少的，前两名回报率是投资茅台的近十倍！天士力无法比确是天士力的优势，未来天士力会涨的你目瞪口呆。而茅台则只有跌多了的优势。","source":"雪球"},{"id":23343795,"user_id":6785033954,"title":"投资要有战略眼光","created_at":1363873138000,"retweet_count":17,"reply_count":46,"fav_count":13,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> 投资要有战略眼光，最基本的常识是要有的，胡JINTAO在18大做报告时专门提到腐败再不解决将会亡党亡国，做为中国腐败指数的茅台前景怎么样可想而知，新上任的国务院总理李说过环境污染已经关乎每个中国人最基础的生存问题，环保行业的未来几年的前景也可想而知。未来几年投资...","type":"3","source_link":null,"edited_at":1363881768000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23343795","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":441,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-21 21:38","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> 投资要有战略眼光，最基本的常识是要有的，胡JINTAO在18大做报告时专门提到腐败再不解决将会亡党亡国，做为中国腐败指数的茅台前景怎么样可想而知，新上任的国务院总理李说过环境污染已经关乎每个中国人最基础的生存问题，环保行业的未来几年的前景也可想而知。未来几年投资什么行业不是很清楚吗，为何非要和最高领导的最高指示做对呢？<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;即使你这次炒到茅台的大底才更危险，为何？因为你会因这次的成功而束缚你以后的投资思想。投资必须要有战略眼光，不要因眼前小利而失长远大利。<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;要想有战略眼光必须要投资最顶尖的上市公司，A股最顶尖的上市公司是天士力而不是茅台，天士力和茅台截然相反的走势是早已注定的。投资天士力才是真正的价值投资，而投资目前的茅台只能算是投机。<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;再再一次提醒,环保概念将是未来五年的顶级主题,未来要想取得超额收益，必须紧紧抓住这一重磅题材，尤其是要寻找政策支持和业绩持续增长的个股，如果后期出现大幅回调，一定不要错过，切记！<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;目前持有兴蓉投资。","source":"雪球"},{"id":23343385,"user_id":6785033954,"title":"","created_at":1363870748000,"retweet_count":5,"reply_count":14,"fav_count":2,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> 民间茅台囤货2万吨，超过四千万瓶，目前茅台销量直线下降，用不了多长时间飞天茅台批发价将跌到800元，零售价会跌破千元。今年量价齐跌，业绩至少下降35%，茅台的投资者要做好承受长达三年煎熬的心理准备。 ","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23343385","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":346,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-21 20:59","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> <strong>民间茅台囤货2万吨，超过四千万瓶，目前茅台销量直线下降，用不了多长时间飞天茅台批发价将跌到800元，零售价会跌破千元。今年量价齐跌，业绩至少下降35%，茅台的投资者要做好承受长达三年煎熬的心理准备。</strong>","source":"雪球"},{"id":23331862,"user_id":6785033954,"title":"","created_at":1363784479000,"retweet_count":1,"reply_count":3,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 尚德破产是否引发国内岌岌可危的光伏产业连锁破产效应?拭目以待。。。","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23331862","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":351,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-20 21:01","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 尚德破产是否引发国内岌岌可危的光伏产业连锁破产效应?拭目以待。。。","source":"雪球"},{"id":23331831,"user_id":6785033954,"title":"","created_at":1363784271000,"retweet_count":4,"reply_count":5,"fav_count":1,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 尚德犯下的最大错误是,没有选择在A股上市。","type":"0","source_link":null,"edited_at":1363784287000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23331831","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":350,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-20 20:57","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 尚德犯下的最大错误是,没有选择在A股上市。","source":"雪球"},{"id":23331763,"user_id":6785033954,"title":"","created_at":1363783802000,"retweet_count":1,"reply_count":2,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 据说破产对施正荣个人资产几乎没有影响，中国的企业家就是这样,先争着上市,捞一笔了再想着怎么把公司变回自己家的,其实就是欺骗投资者的信任,严重缺失责任心。不谈工人失业的事情,就是周围那些做配套的企业要倒掉多少啊。","type":"0","source_link":null,"edited_at":1363783984000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23331763","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":358,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-20 20:50","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 据说破产对施正荣个人资产几乎没有影响，中国的企业家就是这样,先争着上市,捞一笔了再想着怎么把公司变回自己家的,其实就是欺骗投资者的信任,严重缺失责任心。不谈工人失业的事情,就是周围那些做配套的企业要倒掉多少啊。","source":"雪球"},{"id":23331570,"user_id":6785033954,"title":"","created_at":1363782590000,"retweet_count":3,"reply_count":8,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 赛维LDK什么时候破产？","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23331570","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":354,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-20 20:29","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/STP\"   target=\"_blank\">$尚德电力(STP)$</a> 赛维LDK什么时候破产？","source":"雪球"},{"id":23320909,"user_id":6785033954,"title":"","created_at":1363700021000,"retweet_count":3,"reply_count":12,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> 大是大非面前糊涂就是没脑子，当前谁敢喝上千元一瓶的酒,先查查他是不是公款吃喝?是不是贪污犯?是不是和贪官勾结的奸商?抽空去大酒店去看一下，你要是拿出手机对准哪个官员，他能当场吓抽了。现在去大酒店的官员都是走后门的，全国上下无不如此。","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200893,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/23320909","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":354,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-03-19 21:33","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600519\"   target=\"_blank\">$贵州茅台(SH600519)$</a> 大是大非面前糊涂就是没脑子，当前谁敢喝上千元一瓶的酒,先查查他是不是公款吃喝?是不是贪污犯?是不是和贪官勾结的奸商?抽空去大酒店去看一下，你要是拿出手机对准哪个官员，他能当场吓抽了。现在去大酒店的官员都是走后门的，全国上下无不如此。","source":"雪球"}],"page":345};
  SNB.data.statusType = "";
  SNB.data.isSelf = false;
  SNB.data.who = '他';
  SNB.data.route = '';
  seajs.use(['SNB.status.js', 'SNB.newProfile.js']);
})($);</script></div><script>seajs.use(['widget/donate_tooltip'], function () {
  $('body')
    .on('click', function (e) {
      var $this =  $(e.target);
      
      if (!$this.parents('.set-sub-menu').length) {
        $('.set-sub-menu').hide();
      }
    })
    .on('mouseenter', '.status-list li', function () {
      var $this = $(this);
      
      if ($this.find('.btn-sub-menu').length) {
        $this.find('.btn-sub-menu').addClass('hover');
      }
    })
    .on('mouseleave', '.status-list li', function () {
      var $this = $(this);
      
      if ($this.find('.btn-sub-menu').length) {
        $this.find('.btn-sub-menu').removeClass('hover');
      }
    });
});

</script></div></div></div><div id="footer"><div class="risk">提示：雪球里任何用户或者嘉宾的发言，都有其特定立场，投资决策需要建立在独立思考之上。</div><div class="copyright"><a href="/about/faq" target="_blank">常见问题</a><a href="/about/contact-us" target="_blank">联系方式</a><a href="/about/jobs" target="_blank">加入我们</a><a href="/about/company" target="_blank">关于雪球</a><a>© 2015 XUEQIU.COM</a><a href="http://www.miibeian.gov.cn/" target="_blank">京ICP证100666号</a><span>京公网安备 11010502026957</span></div></div><script>var _hmt = _hmt || [];
(function () {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?1db88642e346389874251b5a1eded6e3";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();</script><script>var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-16079156-4']);
_gaq.push(['_setDomainName', 'none']);
_gaq.push(['_trackPageview']);

(function () {
  var ga = document.createElement('script');
  ga.type = 'text/javascript';
  ga.async = true;
  ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
  var s = document.getElementsByTagName('script')[0];
  s.parentNode.insertBefore(ga, s);
})();

window.onerror = function (message, file, line) {
  var sFormattedMessage = '[' + file + ' (' + line + ')]' + message;
  _gaq.push(['_trackEvent', 'Exceptions', 'Application', sFormattedMessage, null, true]);
}</script><script>jQuery(function ($) {
  $('.cube-invite').on('click', function () {
    var href = $.trim($(this).attr('href'));
    if (window._hmt) {
      _hmt.push(['_trackEvent', 'cube-invite', 'click', href]);
    }
  });
});</script></body></html>